Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020044	li-gluk	mmol/l (mmol/l)	8783	11532	0.07%
3020044	li-gluk	— (—)	736	843	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any dementia, excluding more controls

811

1161

5.06

322.70

1.2

3.90

3.82

mmol/l

0.85

756

1088

Visual disturbances

1246

3858

3.36

322.53

1.3

1.4

3.68

3.73

mmol/l

0.93

1160

3626

Mood disorders, excluding more controls

2061

4792

2.67

319.06

1.2

1.3

3.81

3.68

mmol/l

5.31

1922

4519

Dementia, including avohilmo

987

1704

4.15

311.15

1.2

1.3

3.87

3.84

mmol/l

0.36

924

1594

Dementia

913

1488

4.40

309.79

1.2

3.87

3.82

mmol/l

0.61

853

1401

Malaise and fatigue

1187

2351

4.35

307.65

1.3

1.2

3.82

3.76

mmol/l

0.88

1102

2211

General symptoms and signs

3052

4064

3.88

307.65

1.3

1.2

3.74

mmol/l

0.01

2864

3826

Symptoms and signs involving cognition, perception, emotional state and behaviour

3091

5277

4.28

307.65

1.2

1.3

3.78

3.72

mmol/l

2.46

2904

4958

Other symptoms and signs involving cognitive functions and awareness

1898

2315

8.33

307.65

1.2

1.3

3.82

3.77

mmol/l

1.00

1778

2176

Disturbances of skin sensation

936

2247

4.41

307.65

1.2

1.3

3.59

3.70

mmol/l

2.77

871

2106

Alzheimer disease, excluding more controls

525

209

17.83

307.65

1.1

3.81

3.65

mmol/l

1.42

491

198

Other symptoms and signs involving the nervous and musculoskeletal systems

1468

3168

4.91

307.65

1.3

1.4

3.70

3.72

mmol/l

0.32

1393

2986

MS-disease / Multiple Sclerosis

508

539

11.10

307.65

1.1

1.3

3.56

3.67

mmol/l

1.44

470

506

Hydrocephalus

625

400

19.53

307.65

2.1

1.4

3.78

3.79

mmol/l

0.06

607

371

Alzheimer’s disease, wide definition, excluding more controls

474

178

19.26

307.65

1.1

3.77

3.65

mmol/l

0.80

441

169

Normal-pressure hydrocephalus

442

241

24.33

307.65

1.9

1.1

3.92

3.97

mmol/l

0.20

432

218

Other encephalitis

326

167

28.43

307.65

1.6

1.2

3.57

3.77

mmol/l

1.28

311

158

Demyelinating diseases of the central nervous system

623

660

11.18

307.65

1.1

1.3

3.56

3.69

mmol/l

1.90

580

619

Polyneuropathies and other disorders of the peripheral nervous system

720

1423

5.41

307.65

1.6

1.3

3.92

3.85

mmol/l

0.68

679

1326

Other demyelinating diseases of the central nervous system

317

268

14.84

307.65

1.2

1.3

3.53

3.74

mmol/l

2.15

296

251

Inflammatory diseases of the central nervous system

668

591

13.85

307.65

1.7

1.2

3.49

3.78

mmol/l

4.99

631

555

Neurological diseases, wide definition

1059

483

11.47

307.65

1.6

1.4

3.62

3.43

mmol/l

6.32

994

460

Condition for Implicit Sepsis (Organ dysfunction codes)

2426

4855

3.77

307.65

1.3

3.85

3.70

mmol/l

7.39

2275

4571

Migraine

1311

3187

3.62

307.65

1.2

1.3

3.58

3.62

mmol/l

0.62

1229

3003

Convulsions, not elsewhere classified

796

1273

6.53

307.65

1.6

1.3

3.86

3.73

mmol/l

1.98

738

1200

Symptoms and signs involving the nervous and musculoskeletal systems

2041

4491

4.80

307.65

1.4

1.3

3.71

3.74

mmol/l

0.74

1924

4215

Concussion

986

1487

5.90

307.65

1.3

1.4

3.82

3.68

mmol/l

1.97

918

1411

Other degenerative diseases of the nervous system

1317

553

19.80

307.65

1.1

3.72

3.71

mmol/l

0.07

1231

522

Dizziness and giddiness

1594

4311

3.08

307.65

1.3

3.79

3.72

mmol/l

1.49

1501

4057

Headache

2486

3561

6.16

307.65

1.4

1.2

3.63

3.71

mmol/l

2.79

2322

3351

Other headache syndromes

1090

3022

3.74

307.65

1.2

1.3

3.67

3.68

mmol/l

0.11

1012

2847

Psychiatric diseases

2477

4672

2.71

307.65

1.3

3.79

3.66

mmol/l

6.59

2320

4401

Postprocedural disorders of nervous system

500

489

12.00

307.65

1.3

1.1

3.50

3.68

mmol/l

2.83

466

459

Neurological diseases

2629

2042

6.72

307.65

1.4

1.3

3.65

3.69

mmol/l

0.74

2471

1932

Implicit Sepsis

1899

4536

3.37

307.65

1.3

3.90

3.72

mmol/l

8.35

1775

4276

Episodal and paroxysmal disorders

2681

4967

2.83

307.65

1.3

1.4

3.72

3.69

mmol/l

0.75

2502

4679

Visual disturbances and blindness

1317

4130

3.31

307.65

1.3

3.72

3.74

mmol/l

0.34

1224

3884

Encephalitis

340

181

26.97

307.65

1.6

1.2

3.59

3.71

mmol/l

0.70

325

171

Other neurological diseases

2277

4268

4.50

307.65

1.5

1.2

3.76

3.78

mmol/l

0.26

2139

4006

Intracranial trauma

1176

1535

5.88

307.65

1.3

3.83

3.68

mmol/l

2.75

1092

1457

Organic, including symptomatic, mental disorders

1386

2061

5.10

307.65

1.2

1.3

3.91

3.83

mmol/l

1.63

1293

1935

Viral infections of the central nervous system

493

535

10.85

307.65

1.5

1.3

3.62

3.72

mmol/l

0.83

459

500

Fever of other and unknown origin

1273

3089

3.94

307.65

1.7

1.2

3.73

3.75

mmol/l

0.30

1216

2907

Epilepsy

1034

2053

5.30

307.65

1.4

1.5

3.89

3.70

mmol/l

4.83

968

1936

Cerebrovascular diseases

1667

4064

3.03

307.65

1.4

1.2

3.91

3.78

mmol/l

3.68

1552

3827

Cerebrovascular diseases (FINNGEN)

1067

1840

4.35

307.65

1.5

1.2

3.88

3.61

mmol/l

10.33

998

1730

Focal epilepsy

721

1580

4.85

306.67

1.4

1.6

3.86

3.72

mmol/l

2.37

680

1477

Meningitis

341

347

11.71

306.48

1.8

1.2

3.29

3.74

mmol/l

6.33

320

325

Viral encephalitis, not elsewhere classified/unspecified

227

120

27.00

302.46

1.6

1.4

3.85

3.77

mmol/l

0.25

211

113

Any mental disorder

2404

4957

2.48

301.58

1.3

3.79

3.67

mmol/l

5.40

2247

4676

Other mental disorders due to brain damage and dysfunction and to physical disease

415

553

8.18

296.91

1.3

1.2

3.91

3.86

mmol/l

0.31

395

516

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

776

719

5.53

295.05

1.4

1.2

3.73

3.61

mmol/l

1.67

728

672

Abnormal findings on diagnostic imaging of central nervous system

321

319

12.15

294.09

1.3

1.7

3.63

3.75

mmol/l

0.94

296

301

Focal epilepsy, strict definition

675

1459

4.93

292.27

1.4

1.6

3.87

3.72

mmol/l

2.50

638

1365

STROKE

1431

3351

3.06

289.87

1.4

1.2

3.91

3.63

mmol/l

14.94

1342

3153

Cerebral cysts

329

345

11.01

287.87

1.4

1.2

3.68

3.74

mmol/l

0.41

311

322

Alzheimer’s disease (Early onset), excluding more controls

183

40.64

285.53

1.1

3.75

3.67

mmol/l

0.25

172

Alzheimer’s disease (Late onset), excluding more controls

327

152

15.01

282.84

1.2

1.1

3.81

3.70

mmol/l

0.61

302

143

Anxiety disorders, excluding more controls

1777

4518

2.66

280.22

1.3

3.73

3.66

mmol/l

1.88

1650

4255

Abnormalities of gait and mobility

437

665

7.16

277.35

1.4

3.77

3.83

mmol/l

0.51

407

617

Disorders of optic nerve and visual pathways

455

726

6.96

277.35

1.3

1.5

3.59

3.73

mmol/l

1.80

423

685

Any dementia

822

1389

4.33

275.80

1.2

3.90

3.85

mmol/l

0.59

765

1296

Degenerative diseases of the nervous system

748

1277

4.59

275.38

1.1

1.2

3.86

3.91

mmol/l

0.51

696

1193

Focal epilepsy, mode (most common among epilepsy diagnosis)

637

1393

4.87

271.95

1.4

1.6

3.84

3.72

mmol/l

1.54

598

1303

Other and unspecified polyneuropathies, also in other diseases

582

1208

5.13

264.58

1.3

3.97

3.87

mmol/l

0.87

546

1125

Unspecific neurodegenerative disorder

815

1442

4.03

248.51

1.2

3.83

3.87

mmol/l

0.32

763

1348

Delirium, not induced by alcohol and other psychoactive substances

353

490

7.72

242.47

1.3

1.2

4.05

3.87

mmol/l

1.61

321

453

Mood [affective] disorders

2203

6571

2.25

241.58

1.2

1.3

3.79

3.71

mmol/l

2.39

2050

6182

Other antidepressants

2182

5001

2.32

241.42

1.2

1.3

3.80

3.72

mmol/l

2.05

2051

4695

Mood disorders

2203

6574

2.24

240.41

1.2

1.3

3.79

3.71

mmol/l

2.35

2052

6184

Stroke, including SAH

1286

3411

2.86

238.24

1.5

1.3

3.95

3.79

mmol/l

4.05

1200

3202

Depression

2070

6377

2.28

237.09

1.2

1.3

3.78

3.70

mmol/l

2.07

1923

5998

Viral Sepsis

543

1183

4.83

232.20

1.5

1.3

4.00

3.73

mmol/l

4.14

501

1106

Implicit viral Sepsis

539

1179

4.81

229.34

1.5

1.3

4.01

3.74

mmol/l

4.14

497

1102

Infections, IBD-co-morbidities

323

258

9.41

227.56

1.5

1.2

3.82

3.49

mmol/l

5.25

303

243

Spirochaetal infections, other/unspecified

362

570

7.05

223.56

1.2

1.3

3.52

3.80

mmol/l

4.81

332

532

Implicit bacterial Sepsis

814

2221

3.47

219.01

1.5

1.3

4.07

3.80

mmol/l

6.05

744

2090

Pain, not elsewhere classified

594

1462

4.20

215.78

1.3

1.2

3.70

mmol/l

0.06

559

1383

Dorsalgia

2084

5142

2.23

214.35

1.2

1.3

3.73

mmol/l

0.08

1965

4827

General examination and investigation of persons without complaint and reported diagnosis

1393

2804

2.70

210.96

1.4

1.2

3.77

3.71

mmol/l

1.12

1316

2648

N06DA Anticholinesterases

628

1282

4.10

207.07

1.2

3.80

3.90

mmol/l

1.20

582

1190

Use of anticholinesterases

628

1282

4.10

207.07

1.2

3.80

3.90

mmol/l

1.20

582

1190

Alzheimer disease, including avohilmo

663

1222

4.05

206.88

1.1

1.2

3.82

3.90

mmol/l

0.99

620

1132

Bacterial Sepsis

894

2591

3.16

205.79

1.4

1.3

4.05

3.79

mmol/l

6.57

818

2444

Anxiety disorders

1908

6253

2.20

203.39

1.3

3.71

mmol/l

0.04

1773

5885

Medical observation and evaluation for suspected diseases and conditions

1416

2805

2.63

202.85

1.3

1.2

3.78

3.71

mmol/l

1.47

1342

2649

Other meningitis

166

105

21.71

202.29

2.0

1.1

3.33

3.82

mmol/l

3.28

158

Depression or dysthymia

1346

2885

2.66

202.08

1.2

1.3

3.79

3.70

mmol/l

2.15

1250

2720

Neurotic, stress-related and somatoform disorders

1889

6210

2.20

201.48

1.3

3.71

mmol/l

0.01

1755

5843

Alzheimer’s disease, wide definition

489

876

4.85

200.13

1.1

1.2

3.78

3.93

mmol/l

1.96

451

809

Syncope and collapse

805

2266

3.22

192.57

1.4

1.2

3.82

3.78

mmol/l

0.44

755

2132

Symptoms and signs involving the skin and subcutaneous tissue

1432

6178

2.36

191.67

1.3

3.65

3.74

mmol/l

3.16

1341

5804

Other soft tissue disorders, not elsewhere classified

1903

5493

2.18

191.02

1.4

1.3

3.73

3.71

mmol/l

0.26

1784

5162

Stroke, excluding SAH

1135

3188

2.71

190.40

1.4

1.3

3.98

3.79

mmol/l

5.04

1059

2991

Migraine with aura

593

1620

3.80

186.38

1.2

1.3

3.55

3.60

mmol/l

0.70

555

1534

Other dorsopathies, not elsewhere classified

2051

5181

2.12

185.35

1.2

1.3

3.71

3.73

mmol/l

0.41

1929

4864

Certain infectious and parasitic diseases

1993

4711

2.15

183.83

1.4

1.2

3.75

3.68

mmol/l

1.96

1873

4445

Alzheimer disease

566

1069

4.12

183.81

1.1

1.2

3.83

3.92

mmol/l

0.90

525

988

Migraine without aura

530

1362

4.05

182.11

1.3

1.5

3.54

3.56

mmol/l

0.21

499

1290

Autoimmune diseases excluding thyroid diseases

2121

5790

2.07

181.35

1.2

1.4

3.86

3.66

mmol/l

9.98

1984

5440

Status epilepticus

191

185

11.79

176.55

1.5

1.8

4.08

3.69

mmol/l

2.81

180

175

Nerve, nerve root and plexus disorders

2052

6411

2.04

175.88

1.3

1.2

3.84

3.73

mmol/l

3.71

1913

6031

Alzheimer’s disease (Early onset)

183

166

12.11

175.62

1.1

1.2

3.75

3.89

mmol/l

0.63

172

154

Low back pain

1445

4918

2.30

174.99

1.2

1.3

3.70

3.75

mmol/l

1.00

1355

4622

Papilloedema, unspecified

177

159

13.90

174.53

1.4

3.63

3.68

mmol/l

0.17

164

150

Viral meningitis

220

264

9.65

174.01

1.3

1.2

3.34

3.74

mmol/l

5.55

206

247

Diplopia

403

875

4.90

173.84

1.3

3.65

3.80

mmol/l

1.85

381

825

Other disorders of optic [2nd] nerve and visual pathways

285

457

6.94

173.16

1.4

1.6

3.64

3.77

mmol/l

1.01

266

435

Autoimmune diseases excluding thyroid diseases, strict definition

2047

5644

2.05

172.42

1.2

1.4

3.86

3.66

mmol/l

9.12

1915

5301

Recurrent or chronic depression

843

2057

3.03

172.16

1.2

1.3

3.74

3.65

mmol/l

1.64

790

1938

Anxiety (asthma-related co-morbidities)

1274

4309

2.38

166.41

1.2

1.3

3.70

3.64

mmol/l

1.45

1187

4049

Bacterial infection, other or unspecified

1020

3613

2.61

166.26

1.6

1.3

4.00

3.75

mmol/l

5.02

949

3403

Autoimmune diseases related-to ILD

1680

7216

2.08

162.77

1.2

1.3

3.70

3.75

mmol/l

1.05

1563

6790

Lower back pain or/and sciatica

1977

6985

1.99

162.28

1.2

1.3

3.71

3.75

mmol/l

1.05

1861

6551

Pain (limb, back, neck, head abdominally)

1401

3029

2.35

159.17

1.5

1.3

3.72

3.78

mmol/l

1.27

1312

2859

Examination and observation for other reasons

1124

2775

2.51

154.28

1.4

1.2

3.72

3.69

mmol/l

0.30

1067

2623

Cerebral palsy and other paralytic syndromes

369

823

4.77

154.07

1.5

1.4

3.64

3.73

mmol/l

0.79

341

771

ILD medications

2206

6417

1.91

152.57

1.5

1.2

3.69

3.74

mmol/l

1.04

2050

6043

Ischaemic Stroke, excluding all haemorrhages

1002

3017

2.57

152.17

1.3

3.99

3.81

mmol/l

4.45

937

2833

Traumatic subdural haemorrhage

206

258

8.11

150.40

1.5

1.1

4.00

3.71

mmol/l

2.43

189

240

Pain in limb

1519

5248

2.13

149.87

1.4

1.3

3.74

3.71

mmol/l

0.39

1420

4936

Pain in joint

1064

2865

2.50

149.04

1.2

1.3

3.71

3.79

mmol/l

1.33

991

2705

All anxiety disorders

1287

4705

2.25

147.83

1.2

1.3

3.70

3.68

mmol/l

0.34

1199

4426

Guillain-Barre syndrome

129

17.23

143.72

1.3

1.2

3.85

3.71

mmol/l

0.47

124

ILD medications: immunosuppressive drugs

1242

5479

2.22

143.17

1.8

1.3

3.63

3.74

mmol/l

2.48

1164

5165

Dorsopathies

1978

5232

1.96

143.17

1.2

1.3

3.72

3.73

mmol/l

0.19

1864

4913

Disorders of thyroid, IBD co-morbidities

266

300

6.60

143.04

1.4

1.2

3.79

3.47

mmol/l

3.91

251

281

Anaemias

521

956

3.72

142.05

1.6

1.2

3.94

3.46

mmol/l

7.46

489

904

Other special examinations and investigations of persons without complaint or reported diagnosis

1270

2805

2.33

141.32

1.3

1.2

3.79

3.71

mmol/l

1.63

1178

2649

Care involving use of rehabilitation procedures

1250

5538

2.18

138.71

1.4

1.3

3.81

3.73

mmol/l

1.45

1155

5223

Depression medications

681

1093

3.20

135.31

1.2

1.1

3.67

3.47

mmol/l

5.87

637

1029

Parkinson's disease, excluding more controls

185

228

8.13

135.23

1.3

1.1

3.87

3.69

mmol/l

1.40

172

216

Opioids

1917

5294

1.93

134.05

1.2

3.73

3.72

mmol/l

0.16

1802

4981

Used for control exclusion in common control thyroid runs

2004

5411

1.90

133.71

1.2

1.4

3.82

3.67

mmol/l

6.46

1876

5085

Subjective visual disturbances

557

1815

3.18

132.80

1.2

1.3

3.69

3.74

mmol/l

0.65

524

1698

Optic neuritis

204

309

7.38

131.12

1.2

1.3

3.58

3.69

mmol/l

0.72

187

291

Sequelae of cerebrovascular disease

609

1811

3.03

130.74

1.4

1.2

3.96

3.82

mmol/l

1.77

560

1700

Bell's palsy

339

807

4.43

130.04

1.4

1.2

3.81

3.75

mmol/l

0.45

321

756

Parkinson's disease, strict definition, excluding more controls

170

201

8.53

129.60

1.3

1.1

3.87

3.67

mmol/l

1.45

158

190

Aneurysms, operations, SAH

389

1026

3.95

129.21

1.7

1.2

3.68

3.78

mmol/l

0.85

361

955

Parasetamol

1551

3899

2.06

129.18

1.3

1.2

3.75

3.69

mmol/l

1.25

1456

3658

Other anxiety disorders

962

3682

2.37

127.45

1.2

1.3

3.68

3.65

mmol/l

0.50

898

3462

Diseases of the eye and adnexa

1646

4168

2.01

127.19

1.4

1.3

3.76

3.65

mmol/l

2.93

1544

3925

Any gastric operation

1584

3973

2.03

126.21

1.6

1.1

3.65

3.70

mmol/l

1.15

1491

3739

GASTRO-related operations

1584

3973

2.03

126.21

1.6

1.1

3.65

3.70

mmol/l

1.15

1491

3739

Use of donepezil

349

825

4.21

125.92

1.1

1.2

3.81

3.93

mmol/l

1.10

325

759

Other bacterial diseases

1683

6135

1.92

124.97

1.6

1.3

3.98

3.71

mmol/l

10.73

1563

5788

Extrapyramidal and movement disorders

691

2620

2.71

124.07

1.2

1.3

3.85

3.80

mmol/l

0.51

640

2453

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

571

1962

2.99

123.40

1.3

1.2

3.75

3.61

mmol/l

2.61

525

1844

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

212

355

6.57

123.21

1.7

1.2

3.64

3.86

mmol/l

1.42

206

332

Nontraumatic intracranial haemmorrhage

399

1109

3.72

122.32

1.8

1.2

3.82

3.79

mmol/l

0.14

369

1033

ILD medications: prednisolone, methylprednisolone, prednisone

2006

6280

1.83

121.84

1.3

1.2

3.74

mmol/l

0.07

1867

5912

First line medication for Crohn's disease

2073

6329

1.81

120.76

1.6

1.2

3.71

3.73

mmol/l

0.41

1935

5952

Autoimmune diseases

2051

5827

1.82

119.82

1.2

1.4

3.83

3.66

mmol/l

7.11

1919

5475

Selective serotonin reuptake inhibitors

1786

5038

1.89

118.22

1.2

1.3

3.78

3.72

mmol/l

1.67

1684

4731

Sciatica+with lumbago

923

3882

2.30

116.47

1.2

3.72

3.75

mmol/l

0.29

873

3641

Persons encountering health services for specific procedures and health care

1973

6894

1.80

115.46

1.3

3.80

3.70

mmol/l

3.02

1840

6486

Tramadol

1424

4664

1.99

114.99

1.2

3.83

3.75

mmol/l

1.56

1319

4390

Other disorders of fluid, electrolyte and acid-base balance

562

1916

2.91

114.51

1.4

1.3

4.09

3.75

mmol/l

7.20

523

1796

Abnormal involuntary movements

322

812

4.15

114.10

1.5

1.3

3.68

3.76

mmol/l

0.77

299

755

Cardiovascular diseases

1299

3455

2.08

113.11

1.4

3.70

3.54

mmol/l

6.10

1225

3256

Nausea and vomiting

545

1888

2.92

112.30

1.6

1.5

3.84

3.70

mmol/l

1.51

517

1770

Dementia in Alzheimer disease

279

523

4.69

111.88

1.2

3.95

3.92

mmol/l

0.14

262

481

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

240

491

5.24

111.59

1.7

1.2

3.59

3.85

mmol/l

2.05

230

459

Substance abuse, excluding more controls

928

3650

2.26

111.11

1.2

1.3

3.95

3.73

mmol/l

6.47

864

3437

Intracranial injury

1058

4883

2.13

110.95

1.3

1.4

3.81

3.71

mmol/l

2.15

976

4597

Other spirochaetal diseases

550

1971

2.88

110.65

1.2

1.3

3.56

3.78

mmol/l

5.93

507

1849

Speech disturbances, not elsewhere classified

247

526

4.99

109.25

1.3

1.2

3.93

3.82

mmol/l

0.59

228

490

Lyme disease

544

1954

2.88

109.00

1.2

1.3

3.54

3.78

mmol/l

6.69

502

1831

Codeine

1728

5195

1.85

108.61

1.2

3.75

3.73

mmol/l

0.37

1620

4891

Cardiovascular diseases (excluding rheumatic etc)

1339

3909

2.01

107.86

1.4

1.3

3.77

3.54

mmol/l

10.31

1252

3676

Primary_lymphoid and hematopoietic malignant neoplasms

489

1667

3.03

107.72

3.1

1.2

3.66

3.86

mmol/l

2.99

466

1555

Pain in throat and chest

1560

5105

1.89

107.61

1.2

1.3

3.81

3.69

mmol/l

4.43

1452

4805

Other intervertebral disc disorders

1429

4560

1.94

106.77

1.2

3.76

3.77

mmol/l

0.04

1334

4282

Memory loss

232

479

5.12

106.28

1.2

3.70

3.88

mmol/l

1.83

199

447

Primary_lymphoid and hematopoietic malignant neoplasms

489

1682

3.00

105.90

3.1

1.2

3.66

3.88

mmol/l

3.51

466

1578

Alzheimer’s disease (Late onset)

340

778

3.85

105.59

1.1

1.2

3.81

3.93

mmol/l

1.14

310

714

Use of rivastigmine

264

608

4.50

104.84

1.1

1.2

3.79

3.93

mmol/l

1.18

240

557

Benzodiazepine use

1768

7142

1.78

104.37

1.2

1.3

3.82

3.73

mmol/l

2.24

1652

6708

Malignant neoplasm of brain

155

225

7.73

103.78

1.9

1.4

3.75

3.82

mmol/l

0.23

149

210

Other reaction to severe stress, and adjustment disorders

750

3227

2.38

102.73

1.4

1.3

3.76

3.66

mmol/l

1.69

691

3040

Personality disorders, excluding more controls

511

1830

2.86

102.48

1.2

3.92

3.62

mmol/l

6.58

468

1731

Soft tissue disorders

1884

5605

1.77

100.49

1.4

1.3

3.72

3.71

mmol/l

0.14

1760

5266

Migraine without aura and triptan purchases

411

1325

3.22

100.10

1.3

3.48

3.61

mmol/l

2.38

389

1248

Inflammatory bowel disease treatment related agents

2044

6856

1.71

100.10

1.5

1.3

3.72

3.73

mmol/l

0.12

1910

6445

Oral corticosteroids

1879

6584

1.75

100.06

1.3

1.2

3.74

mmol/l

0.01

1752

6190

Metabolic disorders

1631

5646

1.82

99.59

1.3

4.01

3.69

mmol/l

19.80

1530

5310

Symptoms and signs involving the circulatory and respiratory systems

1888

5438

1.76

98.76

1.4

1.3

3.75

3.68

mmol/l

2.05

1772

5115

Persons encountering health services for examination and investigation

1149

2805

2.08

98.18

1.3

1.2

3.80

3.71

mmol/l

1.89

1068

2649

Disorders of ocular muscles, binocular movement, accommodation and refraction

920

4343

2.14

98.14

1.4

3.67

3.69

mmol/l

0.15

852

4096

Explicit Sepsis

693

2804

2.42

98.12

1.9

1.3

4.05

3.73

mmol/l

6.09

635

2644

Any reimbursement code in KELA

1178

2916

2.05

97.14

1.5

1.2

3.74

3.46

mmol/l

15.26

1116

2736

Migraine with aura and triptan purchases

385

1221

3.28

96.45

1.2

1.3

3.53

3.63

mmol/l

1.43

359

1145

Bacterial meningitis

153

238

7.15

95.91

1.9

1.2

3.14

3.74

mmol/l

4.85

139

225

Injuries to the head

1896

7369

1.69

92.06

1.3

3.80

3.71

mmol/l

2.73

1770

6927

Hypothyroidism (congenital or acquired)

510

1025

2.91

91.55

1.2

1.1

3.74

3.47

mmol/l

7.12

479

970

Hypo-osmolality and hyponatraemia

335

1002

3.45

91.51

1.3

4.00

3.76

mmol/l

2.93

311

942

Malignant neoplasm of eye, brain and central nervous system

165

294

6.14

89.98

1.9

1.3

3.72

3.80

mmol/l

0.30

158

274

Other disorders of urethra and urinary system

1183

4669

1.93

89.84

1.3

3.75

3.70

mmol/l

1.01

1109

4382

Alzheimer’s disease (Atypical or mixed), excluding more controls

104

11.02

89.63

1.2

1.1

4.00

3.67

mmol/l

1.29

Hard cardiovascular diseases

1290

4443

1.89

89.63

1.4

1.2

3.98

3.77

mmol/l

6.97

1216

4184

Schizophrenia or delusion, excluding more controls

536

2086

2.60

89.59

1.1

1.3

3.98

3.68

mmol/l

3.74

501

1965

Hypothyroidism and >3 levothyroxin purchases

504

1021

2.89

89.46

1.2

1.1

3.73

3.47

mmol/l

6.92

475

966

Hypothyroidism, levothyroxine purchases

504

1021

2.89

89.46

1.2

1.1

3.73

3.47

mmol/l

6.92

475

966

Non-invasive ventilation

424

1381

2.96

89.08

1.5

1.3

3.70

3.48

mmol/l

3.22

372

1317

Other diseases of urinary system

1763

5809

1.73

88.84

1.3

3.73

3.72

mmol/l

0.17

1650

5460

Spondylopathies

1273

4134

1.89

88.14

1.3

3.80

3.79

mmol/l

0.15

1189

3883

Subarachnoid haemorrhage

245

612

4.19

88.06

1.8

1.2

3.71

3.77

mmol/l

0.28

225

570

Paralytic strabismus

207

457

4.83

87.85

1.4

1.3

3.85

3.82

mmol/l

0.13

200

427

Communicating hydrocephalus

107

125

9.78

86.34

3.0

1.6

3.57

3.81

mmol/l

1.11

102

117

Abnormalities of breathing

1583

5406

1.76

86.29

1.3

3.76

3.68

mmol/l

2.03

1486

5087

Symptoms and signs involving the digestive system and abdomen

1770

5211

1.72

85.68

1.4

1.3

3.74

mmol/l

0.03

1661

4886

Persons encountering health services in other circumstances, wide

2066

6605

1.64

84.42

1.3

3.84

3.70

mmol/l

4.83

1948

6191

Nonorganic sleeping disorders, excluding more controls

360

1197

3.09

82.87

1.3

3.69

3.67

mmol/l

0.11

338

1130

1507

5437

1.76

82.66

1.4

1.3

3.89

3.69

mmol/l

6.30

1395

5135

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1507

5437

1.76

82.66

1.4

1.3

3.89

3.69

mmol/l

6.30

1395

5135

Lumbar disc prolapse

1044

4332

1.94

82.39

1.2

3.74

3.78

mmol/l

0.53

973

4069

Oedema, not elsewhere classified

431

1581

2.76

81.47

1.2

3.86

3.74

mmol/l

1.48

403

1487

Influenza and pneumonia

1801

7227

1.66

80.51

1.4

1.3

3.89

3.68

mmol/l

8.56

1673

6809

Other extrapyramidal and movement disorders in other diseases

423

1566

2.78

80.04

1.2

1.3

3.81

3.80

mmol/l

0.02

392

1466

Bleeding

1326

5459

1.79

79.67

1.5

1.3

3.98

3.76

mmol/l

6.00

1224

5152

Other/unspecified dorsalgia

632

2809

2.28

79.11

1.2

1.3

3.75

3.73

mmol/l

0.23

600

2633

Transient ischemic attack

765

3022

2.13

78.53

1.3

1.2

3.97

3.79

mmol/l

3.69

715

2833

Cervicalgia

381

1349

2.90

78.30

1.2

3.74

3.76

mmol/l

0.18

351

1267

Fall on same level

1996

6977

1.61

78.03

1.3

3.83

3.69

mmol/l

5.89

1859

6579

Codeine or tramadol medication

1938

6669

1.63

77.82

1.2

3.76

3.74

mmol/l

0.31

1815

6260

Hypertensive diseases (excluding secondary)

990

2946

1.98

77.32

1.3

4.04

3.58

mmol/l

21.58

919

2771

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1007

4971

1.90

77.03

1.3

3.79

3.80

mmol/l

0.14

936

4675

Septicaemia

647

2838

2.23

76.50

2.0

1.3

4.09

3.76

mmol/l

5.99

594

2672

Unspecified dementia

172

317

5.03

76.44

1.2

4.27

3.99

mmol/l

1.54

161

289

Symptoms and signs involving speech and voice

578

2529

2.34

76.39

1.2

1.3

3.77

3.76

mmol/l

0.09

534

2374

Strabismus

548

2343

2.40

76.24

1.4

1.5

3.74

3.68

mmol/l

0.72

512

2204

Other and unspecified degenerative diseases of nervous system

10.48

76.14

1.2

3.86

3.71

mmol/l

0.64

Use of other anti-dementia drugs

341

987

3.07

75.68

1.2

1.3

3.84

3.95

mmol/l

1.03

316

904

Use of memantine

341

987

3.07

75.68

1.2

1.3

3.84

3.95

mmol/l

1.03

316

904

Asthma (mode)

1309

4041

1.80

75.60

1.2

3.76

3.68

mmol/l

1.62

1215

3820

Enlarged lymph nodes

271

810

3.43

74.42

1.5

1.3

3.70

3.73

mmol/l

0.16

252

764

Asthma, excluding more controls

1300

3905

1.79

73.93

1.2

3.78

3.67

mmol/l

2.84

1208

3693

Asthma

1319

4016

1.78

73.32

1.2

3.78

3.68

mmol/l

2.49

1225

3795

Benign neoplasm of meninges

232

637

3.81

73.15

1.3

1.2

3.63

3.81

mmol/l

1.66

207

596

Antihypertensive medication - note that there are other indications

1196

3616

1.83

73.09

1.3

1.4

3.74

3.51

mmol/l

11.07

1125

3391

Other septicaemia

580

2535

2.29

73.04

2.1

1.3

4.12

3.76

mmol/l

6.23

532

2389

Diseases of the musculoskeletal system and connective tissue

1011

2646

1.94

71.86

1.5

1.4

3.65

3.68

mmol/l

0.30

947

2499

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

281

882

3.31

71.74

1.8

1.2

3.66

3.89

mmol/l

2.37

266

821

Complications of medical and surgical care

1170

6338

1.78

71.73

1.4

1.2

3.76

3.75

mmol/l

0.09

1095

5954

Myalgia

438

1741

2.58

71.72

1.2

1.3

3.62

3.70

mmol/l

0.99

408

1639

Abdominal and pelvic pain

1698

5208

1.65

71.62

1.3

3.73

3.74

mmol/l

0.07

1600

4883

Other disorders of central nervous system

12.95

71.40

1.6

1.4

3.62

3.59

mmol/l

0.07

Use of teriflunomide

12.21

71.39

1.0

1.3

3.47

3.55

mmol/l

0.30

COPD/asthma/ILD related infections

1763

5446

1.64

71.19

1.3

3.77

3.69

mmol/l

2.73

1643

5143

COPD/asthma related infections

1763

5446

1.64

71.19

1.3

3.77

3.69

mmol/l

2.73

1643

5143

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1584

6967

1.65

70.56

1.6

1.3

3.89

3.71

mmol/l

4.96

1481

6547

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1834

6584

1.60

70.23

1.3

3.78

3.70

mmol/l

2.42

1732

6173

Benign neoplasm: Cerebral meninges

217

589

3.86

69.67

1.3

1.2

3.65

3.82

mmol/l

1.42

194

550

Benign neoplasm of meninges

232

659

3.68

69.58

1.3

1.2

3.63

3.77

mmol/l

1.11

207

615

Other and unspecified visual disturbances

230

650

3.71

69.55

1.2

1.3

3.74

3.79

mmol/l

0.30

208

615

Somatoform disorder

341

1219

2.88

69.13

1.2

1.3

3.66

3.74

mmol/l

0.68

317

1144

Second line medication for Crohn's disease

972

5326

1.85

69.00

1.9

1.2

3.64

3.74

mmol/l

1.93

913

5008

Provisional assignment of new diseases of uncertain etiology

793

4070

1.98

68.94

1.4

1.3

3.82

3.69

mmol/l

2.53

758

3820

L04AX Other immunosuppressants

949

5164

1.87

68.90

1.9

1.3

3.63

3.74

mmol/l

2.15

890

4865

Hemiplegia

153

322

5.05

68.82

1.4

1.3

3.73

3.75

mmol/l

0.09

140

299

Codes for special purposes

793

4077

1.98

68.60

1.4

1.3

3.82

3.69

mmol/l

2.54

758

3827

Sleep disorders (combined)

1624

6595

1.63

68.47

1.3

3.80

3.73

mmol/l

1.97

1525

6201

Cystitis

1386

5027

1.70

68.07

1.3

3.71

3.69

mmol/l

0.30

1299

4719

Complications of surgical and medical care, not elsewhere classified

1572

6982

1.63

67.54

1.4

1.2

3.77

3.74

mmol/l

0.51

1481

6551

Non-follicular lymphoma, hilmo, excluding all cancers

219

611

3.75

67.50

1.9

1.2

3.70

3.92

mmol/l

1.69

208

565

Non-follicular lymphoma

219

611

3.75

67.50

1.9

1.3

3.70

3.88

mmol/l

1.31

208

571

Diffuse large B-cell lymphoma

137

269

5.49

67.11

1.6

1.3

3.77

3.92

mmol/l

0.62

129

254

Migraine, single triptan purchase ok & required. ICD-code if available is included

1343

5407

1.70

66.91

1.2

1.3

3.56

3.71

mmol/l

8.72

1264

5088

Triptan medication for migraine, single purchase ok

1343

5407

1.70

66.91

1.2

1.3

3.56

3.71

mmol/l

8.72

1264

5088

Hypertension, essential

1318

4409

1.73

66.66

1.3

1.2

4.07

3.62

mmol/l

29.41

1227

4145

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

137

271

5.45

66.55

1.6

1.2

3.77

3.91

mmol/l

0.57

129

249

Diffuse large B-cell lymphoma, helper endpoint

137

271

5.45

66.55

1.6

1.2

3.77

3.91

mmol/l

0.57

129

249

Benign neoplasm: Cerebral meninges

217

609

3.74

66.36

1.3

1.2

3.65

3.77

mmol/l

0.85

194

569

Other specific joint derangements/joint disorders

1279

5045

1.72

66.14

1.2

1.3

3.68

3.72

mmol/l

0.62

1197

4745

Spondylosis

799

3542

1.96

66.07

1.3

1.2

3.80

3.82

mmol/l

0.23

756

3327

Other lack of coordination

10.08

65.50

1.4

3.60

3.69

mmol/l

0.31

Symptoms and signs involving the urinary system

1202

5432

1.73

65.35

1.4

1.3

3.84

3.76

mmol/l

1.58

1115

5114

Systemic connective tissue disorders

586

2749

2.17

65.30

1.2

1.3

3.66

3.74

mmol/l

1.02

538

2569

Dysphagia

409

1659

2.52

64.15

1.3

3.75

3.80

mmol/l

0.34

378

1554

Other disorders of eye and adnexa

305

1071

2.95

64.11

1.3

1.4

3.67

3.72

mmol/l

0.37

284

1002

All pneumoniae

1646

7209

1.59

63.49

1.4

1.3

3.89

3.69

mmol/l

6.87

1528

6796

Symptoms and signs concerning food and fluid intake

178

446

4.11

63.42

1.6

1.3

3.77

3.72

mmol/l

0.20

169

418

Cervicobrachial syndrome

391

1577

2.54

62.11

1.3

1.2

3.72

3.75

mmol/l

0.30

372

1480

COPD differential diagnosis

1352

4042

1.69

62.02

1.4

1.2

3.76

3.68

mmol/l

1.87

1263

3821

Diseases of the myoneural junction and muscle

255

825

3.21

62.00

1.4

3.99

3.79

mmol/l

1.85

239

769

Pneumonias (Asthma/COPD co-morbidities)

1629

7189

1.59

61.88

1.4

1.3

3.89

3.70

mmol/l

6.71

1514

6777

Pneumonia, organism unspecified

1445

6483

1.63

61.84

1.4

1.3

3.92

3.70

mmol/l

7.12

1347

6112

ILD differential diagnosis

1350

4041

1.69

61.64

1.4

1.2

3.76

3.68

mmol/l

1.92

1261

3820

Other pulmonary diagnosis

1352

4059

1.68

61.08

1.4

1.2

3.75

3.68

mmol/l

1.47

1265

3835

Acute upper respiratory infections of multiple and unspecified sites

1228

5504

1.69

61.00

1.5

1.2

3.77

3.70

mmol/l

1.54

1141

5176

Excluding asthma or asthma-COPD overlap

1349

4059

1.68

60.45

1.4

1.2

3.76

3.68

mmol/l

1.73

1261

3835

Other disorders of lacrimal gland

566

2708

2.13

60.01

1.4

1.3

3.78

3.72

mmol/l

0.66

525

2527

Acute upper respiratory infections

1664

6694

1.57

59.87

1.4

1.3

3.75

3.72

mmol/l

0.56

1546

6303

1824

6266

1.55

59.76

1.4

1.3

3.77

3.71

mmol/l

1.49

1701

5901

Factors influencing health status and contact with health services

527

1147

2.33

59.68

1.3

1.2

3.83

3.71

mmol/l

1.42

490

1068

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

571

2750

2.12

59.57

1.3

1.2

3.75

3.66

mmol/l

1.32

525

2590

Somnolence, stupor and coma

117

221

5.60

59.52

1.4

1.5

4.15

3.76

mmol/l

2.37

101

206

Behavioural syndromes associated with physiological disturbances and physical factors

600

2942

2.08

59.48

1.4

3.69

3.64

mmol/l

0.68

561

2761

Neuromuscular dysfunction of bladder

202

582

3.61

59.27

1.3

1.2

3.78

3.81

mmol/l

0.12

188

541

Bipolar affective disorders

373

1507

2.54

59.17

1.2

3.78

3.65

mmol/l

1.81

354

1426

Undefined dementia

172

400

4.05

59.03

1.2

4.27

3.95

mmol/l

2.03

161

360

Systemic atrophies primarily affecting the central nervous system

128

265

5.19

59.00

1.6

1.4

3.72

3.87

mmol/l

0.82

119

248

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

148

343

4.49

58.66

1.3

3.72

3.80

mmol/l

0.32

139

315

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1579

7112

1.57

58.57

1.4

1.3

3.90

3.70

mmol/l

6.59

1466

6705

Asthma (only as main-diagnosis), excluding more controls

1123

3905

1.73

58.25

1.3

1.2

3.77

3.67

mmol/l

2.35

1043

3693

Dental caries

476

2131

2.26

58.24

2.4

1.3

4.07

3.73

mmol/l

3.36

448

2015

Asthma (only as main-diagnosis)

1134

4016

1.72

57.80

1.3

1.2

3.77

3.68

mmol/l

1.88

1054

3795

Cerebral aneurysm, nonruptured

194

554

3.65

57.77

1.5

1.2

3.62

3.71

mmol/l

0.64

181

521

Bronchitis

1694

7261

1.54

56.87

1.4

1.3

3.79

3.71

mmol/l

2.08

1573

6829

Endocrine, nutritional and metabolic diseases

1436

4539

1.62

56.79

1.4

3.94

3.47

mmol/l

37.72

1352

4268

Temporomandibular joint disorders

260

896

2.96

56.19

1.3

1.2

3.65

3.70

mmol/l

0.33

244

838

Non-selective monoamine reuptake inhibitors

564

2676

2.07

55.87

1.3

1.2

3.91

3.76

mmol/l

2.58

523

2521

Sleep disorders

422

1854

2.33

55.58

1.3

3.67

3.70

mmol/l

0.33

399

1729

Covid-19 confirmed case

488

2274

2.19

55.47

1.6

1.4

3.81

3.72

mmol/l

0.94

464

2126

Diagnoses used for exclusion with ILD

421

1856

2.32

54.83

1.4

1.3

3.94

3.82

mmol/l

1.02

392

1739

Unspecified mental disorder

716

3840

1.89

54.63

1.2

3.92

3.71

mmol/l

3.07

670

3617

Disorders of lipoprotein metabolism and other lipidaemias

1190

4539

1.66

54.19

1.2

1.3

4.10

3.74

mmol/l

16.59

1114

4269

Viral infections characterized by skin and mucous membrane lesions

694

3699

1.91

53.92

1.5

1.4

3.66

3.74

mmol/l

1.11

658

3492

All influenza

431

1935

2.27

53.74

1.5

1.4

4.01

3.75

mmol/l

3.67

395

1822

Intestinal infectious diseases

1486

7495

1.56

53.51

1.4

1.3

3.86

3.69

mmol/l

5.51

1400

7030

Intracerebral haemorrhage

204

629

3.33

53.51

2.0

1.3

3.89

3.80

mmol/l

0.43

189

577

Falls/tendency to fall

1829

6098

1.51

53.30

1.3

3.79

3.69

mmol/l

3.02

1707

5748

Diarrhoea and gastroenteritis of presumed infectious origin

1127

6269

1.65

52.98

1.3

3.89

3.69

mmol/l

6.20

1056

5868

Hypertensive diseases

1308

4608

1.62

52.69

1.3

4.05

3.61

mmol/l

27.82

1213

4334

Follow-up examination after treatment for conditions other than malignant neoplasms

647

2161

1.98

52.68

1.2

3.72

3.66

mmol/l

0.83

603

2045

Exclusions for E4_PCOS_BROAD

350

1452

2.48

52.60

1.4

1.7

3.67

3.69

mmol/l

0.13

320

1363

Hypertension

1306

4601

1.62

52.56

1.3

4.05

3.61

mmol/l

28.08

1212

4327

Asthma, unspecified (mode), excluding more controls

799

3477

1.83

52.48

1.3

1.2

3.79

3.68

mmol/l

2.33

740

3292

Acute sinusitis

856

4561

1.77

52.27

1.3

1.2

3.77

3.68

mmol/l

1.46

795

4302

Pain in thoracic spine

272

1002

2.78

52.11

1.2

1.3

3.65

3.74

mmol/l

0.90

259

936

Mental and behavioural disorders due to psychoactive substance use

952

5297

1.72

52.06

1.2

1.3

3.94

3.76

mmol/l

4.71

886

4987

L04AA Selective immunosuppressants

405

1799

2.31

52.02

1.6

1.4

3.66

3.73

mmol/l

0.72

379

1690

Substance abuse

928

5204

1.72

51.79

1.2

1.3

3.95

3.77

mmol/l

4.75

864

4897

Poisoning by drugs, medicaments and biological substances

462

2173

2.17

51.43

1.2

1.3

3.84

3.68

mmol/l

2.38

421

2046

Shoulder lesions

1169

4379

1.65

51.32

1.3

3.86

3.77

mmol/l

1.76

1112

4119

Asthma, unspecified (mode)

804

3573

1.80

50.93

1.3

1.2

3.80

3.69

mmol/l

2.02

743

3381

Poisoning by medicine

427

1962

2.23

50.48

1.2

1.3

3.83

3.68

mmol/l

2.06

388

1848

Disorders of adult personality and behaviour

541

2722

2.03

50.17

1.2

1.3

3.91

3.65

mmol/l

5.25

495

2569

Pure hypercholesterolaemia

1030

4139

1.69

50.00

1.3

4.02

3.74

mmol/l

10.24

966

3895

Other diseases of intestines

1725

6736

1.50

49.81

1.3

3.75

3.71

mmol/l

0.70

1608

6344

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

911

5380

1.71

49.29

1.5

1.2

3.77

3.76

mmol/l

0.09

853

5051

Other general symptoms and signs

110

230

4.93

48.90

1.7

3.77

3.63

mmol/l

0.44

101

221

Fibromyalgia

185

570

3.36

48.86

1.2

1.3

3.71

3.66

mmol/l

0.22

171

538

Gastrointestinal diseases

1082

3267

1.68

48.12

1.6

1.3

3.67

3.65

mmol/l

0.26

1021

3082

Certain disorders involving the immune mechanism

354

1537

2.36

48.05

2.3

1.3

3.73

3.77

mmol/l

0.23

325

1441

Paraplegia, diplegia of upper limbs

134

6.61

47.81

1.6

1.4

3.76

3.80

mmol/l

0.07

124

Traumatic subarachnoid haemorrhage

9.55

47.71

1.4

1.1

4.01

3.71

mmol/l

1.02

Personality disorders

511

2569

2.03

47.54

1.2

3.92

3.66

mmol/l

5.07

468

2430

Disorders of lacrimal system

640

3466

1.87

47.48

1.4

1.3

3.78

3.72

mmol/l

0.62

596

3246

Exposure to unspecified factor

1506

7803

1.51

47.25

1.3

3.76

3.72

mmol/l

0.58

1403

7336

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

108

154

5.25

47.18

1.1

1.3

3.73

3.52

mmol/l

1.19

147

Cervical disc disorders

538

2757

1.98

47.16

1.3

1.2

3.75

3.79

mmol/l

0.35

501

2582

Alcohol use disorder, Swedish definition

853

4655

1.72

47.14

1.2

1.3

4.00

3.79

mmol/l

5.25

796

4378

Mental and behavioural disorders due to alcohol, excluding acute intoxication

703

3925

1.81

46.99

1.2

3.99

3.79

mmol/l

4.11

656

3697

Kela-code for severe mental illness

626

3386

1.88

46.65

1.2

3.96

3.72

mmol/l

3.23

586

3188

Other necrotizing vasculopathies (FG)

137

358

4.01

46.58

1.3

1.2

3.83

3.89

mmol/l

0.23

125

335

Dentinal caries

406

1878

2.19

46.52

1.7

1.2

4.14

3.73

mmol/l

3.71

381

1775

Mental and behavioural disorders due to alcohol

801

4532

1.74

46.47

1.2

1.3

3.97

3.78

mmol/l

4.69

750

4267

Herpesviral [herpes simplex] infections

234

853

2.83

46.01

1.4

3.53

3.71

mmol/l

1.83

224

797

893

4912

1.69

45.92

1.2

1.3

4.00

3.78

mmol/l

6.09

835

4618

Other systemic involvement of connective tissue (FG)

404

1870

2.18

45.92

1.2

1.3

3.65

3.73

mmol/l

0.69

370

1757

Other and unspecified nonorganic psychotic disorders

379

1727

2.24

45.81

1.1

1.3

3.95

3.69

mmol/l

1.90

352

1623

Visual field defects

175

543

3.35

45.79

1.4

1.3

3.66

3.87

mmol/l

1.63

161

515

938

5100

1.67

45.64

1.2

1.3

3.98

3.77

mmol/l

6.00

877

4797

Generalized anxiety disorder

295

1208

2.50

45.64

1.1

1.3

3.74

3.64

mmol/l

1.05

284

1145

Use of hypnotics and sedatives

1663

6531

1.48

45.54

1.2

1.3

3.80

3.74

mmol/l

0.98

1546

6154

Other joint disorders

1474

5182

1.53

45.51

1.2

1.3

3.68

3.71

mmol/l

0.47

1388

4868

Oxycodone

507

2492

2.00

45.28

1.4

1.3

3.94

3.83

mmol/l

1.15

469

2361

Disorders of eyelid, lacrimal system and orbit

1250

6357

1.56

45.14

1.4

1.3

3.76

3.74

mmol/l

0.19

1166

5978

Retention of urine

482

2023

2.04

44.91

1.3

3.88

mmol/l

0.02

442

1902

Other functional intestinal disorders

684

3653

1.81

44.84

1.3

1.4

3.83

3.73

mmol/l

1.41

627

3441

Renal tubulo-interstitial diseases

1289

6463

1.54

44.61

1.3

3.98

3.70

mmol/l

11.62

1190

6092

Post-traumatic stress disorder

182

589

3.20

44.36

1.2

3.57

3.58

mmol/l

0.08

167

557

Diseases of the ear and mastoid process

1884

6637

1.45

44.15

1.3

3.69

3.74

mmol/l

1.03

1775

6215

Complications of procedures, not elsewhere classified

1190

6660

1.56

43.86

1.4

1.2

3.78

3.74

mmol/l

0.60

1120

6249

Speech and linguistic disorders, excluding more controls

174

515

3.29

43.86

1.9

2.0

3.62

3.51

mmol/l

0.61

162

481

Nonorganic sleeping disorders

360

1638

2.25

43.73

1.3

3.69

3.67

mmol/l

0.14

338

1532

Other external causes of accidental injury

1354

4423

1.55

43.56

1.3

1.4

3.71

3.68

mmol/l

0.47

1268

4166

707

4017

1.77

43.45

1.3

1.4

3.80

3.69

mmol/l

1.67

657

3780

Persons encountering health services in other circumstances

596

3245

1.86

43.36

1.3

1.4

3.92

3.67

mmol/l

2.99

558

3050

Other diseases of spinal cord

165

5.56

43.23

1.7

1.1

3.65

3.76

mmol/l

0.35

154

Asthma, hospital admission 2, infections

885

5302

1.66

43.17

1.3

1.4

3.80

3.71

mmol/l

1.59

823

4979

Asthma-related infections

885

5302

1.66

43.17

1.3

1.4

3.80

3.71

mmol/l

1.59

823

4979

Radiculopathy

256

1007

2.60

43.05

1.2

3.85

mmol/l

0.03

240

937

Specific personality disorders

440

2179

2.06

42.79

1.2

3.89

3.66

mmol/l

3.84

402

2053

Other sleep disorders

187

627

3.06

42.73

1.1

1.3

3.57

3.77

mmol/l

2.30

181

588

Disorders of vestibular function (Vertigo)

658

3686

1.80

42.68

1.2

1.3

3.74

3.77

mmol/l

0.38

624

3443

Zoster [herpes zoster]

282

1167

2.47

42.65

1.7

1.3

3.74

3.81

mmol/l

0.45

265

1084

External causes of morbidity and mortality

1114

3502

1.61

42.34

1.4

1.3

3.69

3.68

mmol/l

0.22

1033

3297

Schizophrenia, schizotypal and delusional disorders

540

2894

1.90

41.54

1.2

3.98

3.72

mmol/l

2.89

505

2722

Suicide or other Intentional self-harm

443

2223

2.03

41.52

1.2

1.3

3.86

3.69

mmol/l

2.36

403

2092

Other acute disseminated demyelination

8.47

41.46

1.3

1.2

3.62

3.60

mmol/l

0.03

Acute tubulo-interstitial nephritis

909

4975

1.64

41.43

1.3

3.96

3.70

mmol/l

8.12

839

4685

Dissociative [conversion] disorders

108

259

4.40

41.42

1.2

1.3

3.75

3.67

mmol/l

0.26

100

239

Dementia in other diseases classified elsewhere

199

4.89

41.01

1.2

3.56

3.89

mmol/l

2.31

183

Accidents

1338

4423

1.53

40.82

1.3

1.4

3.71

3.68

mmol/l

0.38

1251

4166

Schizophrenia or delusion

536

2883

1.89

40.78

1.1

1.2

3.98

3.72

mmol/l

2.93

501

2712

Diseases of oesophagus, stomach and duodenum

1621

6818

1.46

40.67

1.2

1.3

3.83

3.73

mmol/l

2.32

1498

6428

Other necrotizing vasculopathies

152

467

3.39

40.55

1.3

1.2

3.82

3.86

mmol/l

0.21

139

440

Other and unspecified nerve root and plexus disorders, also in other diseases

309

1362

2.32

40.50

1.2

1.3

3.72

3.73

mmol/l

0.07

284

1280

Triptan medication for migraine, min. 3 purchases

920

4504

1.63

40.39

1.2

1.3

3.53

3.66

mmol/l

5.17

863

4232

Spinal stenosis

651

2882

1.79

40.29

1.3

1.2

3.87

3.84

mmol/l

0.33

604

2710

253

1027

2.53

40.02

1.4

1.3

3.75

3.66

mmol/l

0.55

229

956

Other viral diseases

519

2774

1.90

39.98

1.6

1.4

3.63

3.66

mmol/l

0.30

486

2610

Alcohol use disorder, ICD-based

635

3616

1.78

39.96

1.2

1.3

3.99

3.79

mmol/l

3.97

588

3406

Finngen Rheumatological endpoints

1548

6072

1.46

39.66

1.2

1.3

3.73

mmol/l

0.00

1444

5708

Other disorders of binocular movement

160

5.47

39.61

1.2

1.5

3.47

3.68

mmol/l

1.12

149

Insomnia

300

1324

2.32

39.33

1.3

3.67

mmol/l

0.01

280

1242

Neoplasms

1326

4737

1.51

39.29

1.9

1.2

3.66

3.71

mmol/l

1.07

1250

4452

Dyspnoea

1293

6662

1.50

39.19

1.3

3.77

3.75

mmol/l

0.36

1216

6255

Ocular pain

177

607

3.03

39.17

1.5

3.76

3.69

mmol/l

0.35

167

573

Arthropathies

1501

5215

1.48

39.08

1.2

1.4

3.70

3.71

mmol/l

0.12

1409

4900

Psychotic depression

110

278

4.08

39.01

1.3

1.4

3.95

3.70

mmol/l

0.91

101

262

Other systemic involvement of connective tissue

412

2063

2.03

38.81

1.2

1.3

3.66

3.74

mmol/l

0.84

377

1931

Progressive vascular leukoencephalopathy

116

6.17

38.58

1.2

1.3

3.89

3.91

mmol/l

0.03

106

Unspecified fall

706

4147

1.71

38.54

1.3

1.4

3.83

3.73

mmol/l

1.58

662

3901

Alcohol abuse, main dg, excluding more controls

234

932

2.56

38.42

1.2

1.3

3.94

3.73

mmol/l

2.21

220

882

Panic disorder

271

1167

2.37

37.56

1.2

1.3

3.66

3.64

mmol/l

0.14

256

1108

Cluster headache, strict

184

4.85

37.03

1.3

1.1

3.68

3.73

mmol/l

0.12

172

Disorders of other endocrine glands

660

3825

1.72

36.74

1.4

3.75

3.68

mmol/l

0.82

615

3597

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

817

5083

1.62

36.71

1.4

1.2

3.75

3.76

mmol/l

0.08

765

4766

Coxibs

444

1183

2.02

36.43

1.2

1.3

3.67

3.87

mmol/l

2.67

415

1109

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

496

2673

1.86

36.26

2.4

1.3

3.60

3.59

mmol/l

0.07

456

2518

Diseases of inner ear

738

4401

1.66

36.10

1.2

1.3

3.73

3.78

mmol/l

0.67

697

4120

Endovascular or surgical operations to intracerebral aneurysms

134

410

3.40

36.02

1.8

1.2

3.56

3.76

mmol/l

1.37

127

386

Diseases of the respiratory system

1024

3285

1.57

35.87

1.4

1.3

3.73

3.69

mmol/l

0.73

949

3104

Cluster headache, wide

201

4.58

35.86

1.3

1.1

3.65

3.73

mmol/l

0.27

188

Hypothyroidism, strict autoimmune

1026

4410

1.55

35.86

1.2

1.3

3.79

3.65

mmol/l

3.43

958

4143

ILD medications: azathioprine

266

1160

2.34

35.86

1.4

1.3

3.78

3.71

mmol/l

0.38

251

1099

Other and unspecified myopathies

160

545

3.04

35.80

1.4

4.10

3.83

mmol/l

1.79

148

507

Benign neoplasm of brain and other parts of central nervous system

139

440

3.29

35.38

1.7

1.2

3.56

3.85

mmol/l

2.11

128

408

Genitourinary diseases

1002

3212

1.58

35.36

1.4

3.76

3.72

mmol/l

0.48

939

3032

Asthma (diagnoses ohter than nonallergic)

1280

7531

1.46

35.28

1.3

3.77

3.71

mmol/l

1.16

1189

7083

Osteopathies and chondropathies

773

4547

1.63

35.02

1.4

1.3

3.83

3.75

mmol/l

0.88

730

4273

Constipation

1240

6049

1.48

35.01

1.3

1.4

3.85

3.74

mmol/l

2.79

1137

5718

Other diseases of blood and blood-forming organs, wide

345

1687

2.08

34.86

2.1

1.4

3.82

3.78

mmol/l

0.21

327

1584

Other complications of surgical and medical care, not elsewhere classified

185

693

2.75

34.65

1.4

1.3

3.79

3.72

mmol/l

0.36

176

652

Other symptoms and signs involving general sensations and perceptions

187

4.64

34.43

1.2

1.4

3.53

3.69

mmol/l

1.07

177

Hypopituitarism

160

568

2.93

33.36

1.3

2.1

3.70

3.68

mmol/l

0.09

147

530

Secondary parkinsonism+Parkinsonism in other disease

142

5.23

33.07

1.4

1.2

4.18

3.81

mmol/l

1.24

133

Sarcoidosis

237

1022

2.38

32.92

1.5

1.3

3.79

3.80

mmol/l

0.04

219

954

Asthma, including avohilmo

1769

7499

1.38

32.78

1.2

1.3

3.76

3.72

mmol/l

0.90

1647

7051

Other strabismus

376

1939

1.97

32.46

1.4

1.6

3.67

3.66

mmol/l

0.12

346

1828

Benign neoplasm of brain and other parts of central nervous system

139

464

3.11

32.38

1.7

1.4

3.56

3.83

mmol/l

1.96

128

436

Abnormalities of heart beat

501

2808

1.79

32.34

1.3

3.69

3.71

mmol/l

0.19

461

2634

Cervicocranial syndrome

180

688

2.68

32.33

1.2

3.77

3.76

mmol/l

0.04

170

647

Rotator cuff syndrome

835

3960

1.58

32.20

1.2

1.3

3.86

3.80

mmol/l

0.90

795

3738

Injuries to the abdomen, lower back, lumbar spine and pelvis

548

3164

1.74

32.14

1.3

3.74

3.76

mmol/l

0.16

502

2977

Azathioprine

266

1221

2.23

31.77

1.4

1.3

3.78

3.70

mmol/l

0.44

251

1154

Secondary parkinsonism

144

5.08

31.56

1.4

1.2

4.18

3.80

mmol/l

1.25

134

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

308

1501

2.10

31.54

1.2

1.3

3.85

3.66

mmol/l

2.25

281

1415

Brain meningioma, excluding all cancers (controls excluding all cancers)

116

354

3.43

31.47

1.4

1.2

3.51

3.86

mmol/l

2.60

105

330

Other problems related to primary support group, including family circumstances

234

998

2.34

31.33

3.8

1.4

3.53

3.55

mmol/l

0.11

220

947

Brachial plexus disorders

178

689

2.66

31.27

1.2

3.56

3.63

mmol/l

0.59

172

653

Use of peginterferon beta-1a

14.64

31.18

1.0

1.3

3.27

3.52

mmol/l

1.61

Cough

582

3323

1.70

31.16

1.6

1.4

3.72

3.70

mmol/l

0.18

531

3124

Unknown and unspecified causes of morbidity

112

335

3.43

31.06

1.3

1.2

3.80

3.74

mmol/l

0.16

104

317

Other acute lower respiratory infections

748

4526

1.59

30.98

1.4

3.82

3.72

mmol/l

1.49

692

4258

Use of levodopa decarboxylase inhibitor

186

740

2.57

30.78

1.3

1.2

3.84

3.93

mmol/l

0.64

175

681

Benign neoplasms

1238

4854

1.45

30.71

1.3

1.2

3.72

3.73

mmol/l

0.05

1160

4566

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

496

2850

1.76

30.48

1.4

3.75

3.69

mmol/l

0.56

462

2677

Sleep apnoea

1292

6170

1.43

30.43

1.2

1.3

3.86

3.75

mmol/l

3.10

1209

5798

Other CVD (FINNGEN)

177

531

2.68

30.27

1.4

1.2

3.94

3.62

mmol/l

2.81

162

497

Pneumonitis due to solids and liquids

134

454

3.03

30.27

1.4

1.3

4.22

3.84

mmol/l

2.16

126

418

Phobic anxiety disorders

233

1033

2.30

30.26

1.4

3.67

3.63

mmol/l

0.19

219

976

Transport accidents

676

3727

1.62

30.06

1.2

1.3

3.73

3.68

mmol/l

0.62

637

3507

Dermatitis and eczema

1600

7667

1.38

30.04

1.3

3.71

3.73

mmol/l

0.29

1493

7207

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

167

640

2.69

29.99

1.3

3.90

3.75

mmol/l

0.96

151

606

Gastro-oesophageal reflux disease

957

5700

1.50

29.94

1.2

1.3

3.78

3.75

mmol/l

0.26

881

5384

Alzheimer’s disease (Atypical or mixed)

105

308

3.47

29.84

1.2

1.3

3.99

4.01

mmol/l

0.04

279

Fungal Sepsis

214

4.12

29.80

1.4

1.2

3.89

3.77

mmol/l

0.30

201

Injury, poisoning and certain other consequences of external causes

861

2777

1.57

29.63

1.5

1.3

3.69

3.66

mmol/l

0.48

800

2609

Invasive ventilation

147

532

2.86

29.60

1.4

1.6

3.93

3.76

mmol/l

0.82

132

498

Emotionally unstable personality disorder

237

1072

2.26

29.46

1.1

1.2

3.92

3.59

mmol/l

3.92

214

1004

Brain meningioma

111

344

3.37

29.40

1.4

1.2

3.54

3.82

mmol/l

1.93

100

323

Implicit fungal Sepsis

186

4.35

29.34

1.5

1.2

3.80

3.77

mmol/l

0.06

176

Lymphoid leukaemia

112

349

3.34

29.33

8.2

1.2

3.41

3.88

mmol/l

6.00

107

323

Persistent mood disorders

291

1426

2.07

29.28

1.1

1.3

3.92

3.71

mmol/l

2.13

263

1345

Other viral diseases, not elsewhere classified

321

1627

2.00

29.24

1.8

1.6

3.61

3.65

mmol/l

0.40

304

1538

Sleep apnoea, including avohilmo

1379

6419

1.40

29.01

1.2

1.3

3.85

3.74

mmol/l

3.11

1287

6028

Obesity related asthma

483

2798

1.75

28.86

1.3

3.89

3.76

mmol/l

1.84

452

2640

Complications of other internal prosthetic devices, implants and grafts

228

3.95

28.85

2.3

1.3

3.79

3.78

mmol/l

0.04

216

Hypothyroidism, drug reimbursement

207

615

2.44

28.83

1.3

1.1

3.89

3.48

mmol/l

5.28

200

580

Inflammatory diseases of female pelvic organs

884

4428

1.52

28.62

1.2

3.66

3.61

mmol/l

0.74

820

4157

severe traumatic brain injury, does not include concussion

293

1452

2.05

28.57

1.4

1.2

4.01

3.86

mmol/l

1.18

267

1352

Visual impairment including blindness (binocular or monocular)

121

401

3.11

28.49

1.4

1.5

4.17

3.85

mmol/l

1.18

107

381

Optic atrophy

108

5.58

28.16

1.4

1.7

3.77

3.65

mmol/l

0.24

100

Benign neoplasm: Pituitary gland, craniopharyngeal duct

110

348

3.29

28.14

1.2

3.43

3.80

mmol/l

4.08

322

Other and unspecified mood [affective] disorders

140

508

2.84

27.97

1.1

1.4

3.65

3.58

mmol/l

0.32

127

478

Dermatitis

841

5626

1.51

27.52

1.4

1.3

3.76

3.74

mmol/l

0.24

785

5296

Other heart diseases

719

3027

1.58

27.48

1.3

1.4

3.92

3.57

mmol/l

11.01

671

2853

Neuralgia and neuritis, unspecified

103

320

3.34

27.11

1.3

3.70

3.76

mmol/l

0.19

299

Other and unspecified anaemias

499

2869

1.70

26.96

1.6

1.3

4.00

3.82

mmol/l

2.39

465

2689

Rheumatism, unspecified

216

976

2.26

26.89

1.2

1.3

3.74

mmol/l

0.03

204

920

Type 2 diabetes, wide definition

1078

4892

1.45

26.88

1.3

1.2

4.82

3.55

mmol/l

105.48

1003

4600

Other and unspecified dermatitis

710

4609

1.56

26.83

1.4

1.3

3.77

3.73

mmol/l

0.51

663

4331

Injuries to the thorax

587

3646

1.63

26.80

1.2

1.3

3.85

3.79

mmol/l

0.56

543

3433

Lymphoid leukaemia

112

370

3.14

26.65

8.2

1.3

3.41

3.83

mmol/l

5.30

107

345

Hyperkinetic disorders, excluding more controls

171

680

2.50

26.65

1.1

1.8

3.63

3.49

mmol/l

1.16

162

639

Open wound of head

680

4310

1.57

26.61

1.3

1.4

3.85

3.76

mmol/l

1.22

638

4061

Other anaemias

502

2893

1.69

26.61

1.6

1.3

4.00

3.82

mmol/l

2.27

468

2713

Aplastic and other anaemias

540

3118

1.66

26.49

1.6

1.3

4.02

3.81

mmol/l

3.05

503

2923

Other disorders of nervous system

116

394

3.04

26.23

1.7

1.1

3.96

3.80

mmol/l

0.53

107

372

Hypokalaemia

170

702

2.47

26.08

1.6

1.3

3.86

3.70

mmol/l

0.81

155

653

Abnormal findings on examination of blood, without diagnosis

600

3524

1.61

26.02

1.3

4.07

3.82

mmol/l

3.80

563

3312

Asthma, hospital admissions , main diagnosis only

1176

7562

1.40

25.91

1.3

3.76

3.71

mmol/l

0.85

1094

7108

Asthma-related pneumonia or sepsis

464

2735

1.71

25.89

1.4

3.89

3.73

mmol/l

2.17

426

2575

Asthma, hospital admissions 3, pneumonia

464

2735

1.71

25.89

1.4

3.89

3.73

mmol/l

2.17

426

2575

Disorders of refraction and accommodation

411

2340

1.77

25.84

1.5

3.56

3.66

mmol/l

1.44

379

2211

Other and unspecified effects of external causes

431

2498

1.75

25.82

1.2

1.4

3.70

3.67

mmol/l

0.32

408

2349

Diffuse brain injury

5.96

25.80

1.3

1.1

4.11

3.75

mmol/l

0.90

Benign neoplasm: Pituitary gland, craniopharyngeal duct

110

367

3.12

25.77

1.2

1.3

3.43

3.78

mmol/l

3.78

343

Asthma-related pneumonia

462

2727

1.71

25.66

1.4

3.89

3.73

mmol/l

2.19

425

2569

Diseases of the skin and subcutaneous tissue

1550

5755

1.36

25.59

1.4

1.3

3.78

3.70

mmol/l

1.87

1454

5405

Chronic lower respiratory diseases

1796

7375

1.32

25.42

1.3

3.77

3.71

mmol/l

0.97

1670

6939

Other nutritional deficiencies

920

6218

1.46

25.41

1.2

1.3

4.03

3.67

mmol/l

13.98

849

5845

Cardiac arrhythmias

887

3981

1.48

25.30

1.2

1.3

3.76

3.48

mmol/l

13.72

826

3761

Other enthesopathies

413

2379

1.76

25.22

1.2

1.3

3.76

3.74

mmol/l

0.15

391

2240

Diseases of pulp and periapical tissues

505

3072

1.66

25.18

1.4

1.2

3.87

3.73

mmol/l

1.87

474

2890

Focal brain injury

154

4.29

25.13

1.4

1.1

3.99

3.68

mmol/l

1.09

141

Giant cell arteritis

247

3.60

24.98

1.2

3.78

3.88

mmol/l

0.44

233

Hypotension

201

910

2.25

24.88

1.4

1.2

3.91

3.90

mmol/l

0.01

183

837

Disorders of psychological development

230

1015

2.15

24.86

1.7

1.9

3.58

3.55

mmol/l

0.14

217

953

Disorders of sclera, cornea, iris and ciliary body

752

5027

1.51

24.81

1.2

1.3

3.81

3.75

mmol/l

0.65

709

4712

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

663

2692

1.58

24.72

1.3

1.2

3.72

3.58

mmol/l

3.00

623

2527

Agranulocytosis

186

821

2.32

24.64

2.2

1.3

3.74

3.75

mmol/l

0.05

179

765

Other medical care

506

3022

1.65

24.58

1.5

1.3

3.68

3.77

mmol/l

1.00

480

2838

Hypothyroidism, other/unspecified

1264

6075

1.38

24.50

1.2

1.3

3.78

3.71

mmol/l

1.39

1182

5699

Other and unspecified drugs and medicaments

151

610

2.55

24.44

1.3

3.89

3.75

mmol/l

0.79

136

571

Polyarthropathies

950

4391

1.45

24.36

1.3

3.83

3.75

mmol/l

1.11

886

4130

Injuries to the ankle and foot

1013

6539

1.42

24.25

1.3

3.75

3.69

mmol/l

1.03

953

6136

Injuries to the shoulder and upper arm

1132

6841

1.40

24.22

1.3

3.80

3.76

mmol/l

0.58

1061

6434

Benign neoplasms

1471

6106

1.35

24.20

1.3

3.72

3.73

mmol/l

0.20

1380

5754

Other bacterial intestinal infections

249

1240

2.04

24.09

1.5

1.3

3.78

3.77

mmol/l

0.08

237

1147

Infections of the skin and subcutaneous tissue

815

5551

1.47

23.95

1.6

1.3

3.93

3.71

mmol/l

4.48

775

5215

Benign paroxysmal vertigo

371

2106

1.79

23.93

1.3

3.69

3.78

mmol/l

1.01

354

1973

Disorders of the thyroid gland

1346

6494

1.36

23.89

1.2

1.3

3.76

3.72

mmol/l

0.61

1262

6097

Cramp and spasm

102

341

3.12

23.87

1.4

1.2

3.71

3.81

mmol/l

0.49

322

Parkinson's disease, including avohilmo

205

953

2.19

23.83

1.3

1.2

3.90

3.91

mmol/l

0.07

191

884

Functional dyspepsia

374

2132

1.78

23.77

1.2

1.3

3.79

3.72

mmol/l

0.58

351

2005

Hypothyreosis and Thyroxine purchase for inclusion criteria

1293

6279

1.37

23.49

1.2

1.3

3.78

3.71

mmol/l

1.50

1209

5896

Substance use, excluding alcohol

305

1643

1.89

23.43

1.2

1.3

3.83

3.70

mmol/l

1.13

279

1547

Temporal arteritis

219

3.68

23.42

1.2

3.75

3.83

mmol/l

0.34

208

Giant cell arteritis with polymyalgia rheumatica

219

3.68

23.42

1.2

3.75

3.84

mmol/l

0.37

208

Acute bronchitis

537

3306

1.61

23.40

1.3

1.4

3.77

3.73

mmol/l

0.39

491

3105

Irritable bowel syndrome

402

2351

1.73

23.34

1.2

1.3

3.71

3.69

mmol/l

0.16

381

2217

Polyuria

296

1582

1.90

23.28

1.2

3.70

3.83

mmol/l

1.25

271

1480

Vascular dementia

261

3.31

23.26

1.3

4.34

4.00

mmol/l

1.39

233

Benign neoplasm: Brain, supratentorial

108

5.08

23.12

2.0

1.6

3.53

3.70

mmol/l

0.41

Deposits [accretions] on teeth

139

534

2.59

23.11

5.4

1.4

3.63

3.66

mmol/l

0.07

128

505

Other arthritis (FG)

427

2545

1.70

23.09

1.2

1.3

3.79

3.76

mmol/l

0.22

404

2394

Other disorders of ear

1257

6158

1.37

22.99

1.3

3.75

3.77

mmol/l

0.35

1175

5799

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

335

1694

1.83

22.95

1.6

3.61

3.52

mmol/l

1.09

314

1597

Injuries to the wrist and hand

1411

7671

1.34

22.93

1.2

1.3

3.72

3.73

mmol/l

0.18

1324

7203

Exposure to other specified factors

1049

7089

1.40

22.89

1.3

3.67

3.73

mmol/l

1.25

980

6666

Supplementary factors related to causes of morbidity and mortality classified elsewhere

433

2598

1.69

22.87

1.5

1.4

3.82

3.72

mmol/l

0.93

403

2443

Propionic acid derivatives

442

1291

1.74

22.84

1.4

1.5

3.68

3.82

mmol/l

1.63

409

1214

Vocal cord dysfunction

184

769

2.25

22.82

1.3

1.4

3.70

3.46

mmol/l

2.64

172

725

Other specified/unspecified arthritis

372

2143

1.76

22.80

1.2

1.3

3.76

3.75

mmol/l

0.09

351

2010

Restless leg syndrome

187

855

2.24

22.77

1.1

1.3

3.76

3.77

mmol/l

0.03

177

799

Injuries to the neck

350

1989

1.79

22.57

1.2

1.3

3.61

3.71

mmol/l

1.51

329

1861

Congenital malformations of the nervous system

183

3.95

22.57

1.7

3.3

3.54

3.55

mmol/l

0.01

173

Enthesopathies of lower limb, excluding foot

294

1589

1.87

22.32

1.2

1.3

3.67

3.76

mmol/l

0.77

273

1492

Lesion of lateral popliteal nerve

323

3.08

22.19

1.3

1.2

3.56

3.80

mmol/l

1.80

302

Speech and linguistic disorders

175

754

2.28

22.17

1.9

2.1

3.62

3.54

mmol/l

0.38

162

704

Benign neoplasm: Brain, supratentorial

112

4.89

22.15

2.0

1.2

3.53

3.78

mmol/l

0.69

104

Specific development disorders of speech and language

129

487

2.63

22.14

1.7

2.4

3.64

3.56

mmol/l

0.29

120

455

Other shoulder lesions

151

638

2.42

22.13

1.3

3.71

3.80

mmol/l

0.46

146

605

Somnolence

5.81

22.06

1.4

1.8

4.03

3.60

mmol/l

1.25

Leukaemia of unspecified cell type

7.83

22.06

7.8

1.1

3.48

3.80

mmol/l

0.82

Immunodeficiency with predominantly antibody defects

182

3.88

21.89

2.3

1.4

3.64

3.66

mmol/l

0.05

171

Benign neoplasm of other and unspecified endocrine glands

193

908

2.17

21.88

1.2

3.65

3.84

mmol/l

1.84

176

848

Viral pneumonia

193

909

2.16

21.79

1.4

3.94

3.74

mmol/l

1.15

179

849

Other disorders of teeth and supporting structures

301

1653

1.85

21.76

1.3

1.2

3.98

3.77

mmol/l

2.15

283

1558

Carpal tunnel syndrome

764

4736

1.47

21.74

1.2

3.88

3.74

mmol/l

2.27

719

4461

Other and unspecified paralytic syndromes

5.70

21.74

1.2

3.69

3.77

mmol/l

0.19

Irregular menses

694

3796

1.50

21.42

1.3

1.2

3.62

3.59

mmol/l

0.39

654

3561

Pain and other conditions associated with female genital organs and menstrual cycle

322

1736

1.80

21.41

1.2

3.56

3.57

mmol/l

0.12

297

1626

Sequelae of external causes of morbidity and mortality

331

1881

1.78

21.35

1.4

1.3

3.73

3.79

mmol/l

0.42

308

1758

Trigeminal neuralgia

103

369

2.87

21.23

1.3

3.59

3.76

mmol/l

1.03

346

Temporomandibular joint disorders, including avohilmo

611

4047

1.52

21.07

1.2

3.59

3.64

mmol/l

0.58

576

3796

Lung diseases due to external agents

179

830

2.19

20.99

1.4

1.3

4.14

3.87

mmol/l

1.77

168

767

Type of accident

397

2385

1.68

20.93

1.5

1.4

3.82

3.73

mmol/l

0.71

369

2242

Statin medication

1017

4099

1.40

20.80

1.3

4.04

3.58

mmol/l

21.57

953

3834

Osteoporosis

296

1560

1.83

20.79

1.7

1.3

3.74

3.79

mmol/l

0.27

281

1459

Chronic sinusitis

594

3925

1.53

20.79

1.2

1.3

3.72

3.75

mmol/l

0.31

547

3695

Fracture of rib(s), sternum and thoracic spine

366

2156

1.72

20.75

1.2

3.89

3.87

mmol/l

0.12

340

2026

Paracetamol of NSAID medication

278

725

1.95

20.72

1.8

1.6

3.68

3.71

mmol/l

0.21

258

689

Special screening examination for infectious and parasitic diseases

338

1436

1.78

20.66

1.2

3.52

3.58

mmol/l

0.70

307

1353

Cluster headache, strict, including avohilmo

101

365

2.87

20.57

1.3

1.2

3.67

3.73

mmol/l

0.22

336

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

713

4796

1.47

20.54

1.3

3.71

3.78

mmol/l

1.18

668

4524

Bacterial intestinal infections, IBD co-morbidities

242

1268

1.94

20.31

1.5

1.3

3.83

3.81

mmol/l

0.11

230

1175

Other CVD

222

1129

1.99

20.29

1.4

1.3

3.89

3.87

mmol/l

0.13

201

1045

Superficial injury of head

310

1755

1.79

20.26

1.3

1.5

3.74

3.71

mmol/l

0.23

298

1646

Dentofacial anomalies [including malocclusion]

416

2523

1.65

20.22

2.2

1.2

3.61

3.63

mmol/l

0.22

394

2379

Cluster headache, wide,, including avohilmo

104

387

2.78

20.03

1.3

1.2

3.64

3.74

mmol/l

0.40

358

Allergic asthma (mode), excluding more controls

337

1924

1.74

19.94

1.2

1.3

3.66

3.59

mmol/l

0.68

321

1815

Disorders of speech understanding and production

338

2.90

19.79

1.7

2.8

3.74

3.57

mmol/l

0.61

316

Allergic asthma (mode)

337

1930

1.73

19.74

1.2

1.3

3.66

3.60

mmol/l

0.56

321

1823

Iridocyclitis

317

1822

1.76

19.72

1.3

3.77

3.75

mmol/l

0.10

298

1704

Heterophoria

146

646

2.32

19.38

1.6

1.7

3.74

3.65

mmol/l

0.53

135

612

Hypoglycaemia, other or unspecified

121

494

2.52

19.25

1.6

1.8

4.61

3.72

mmol/l

5.37

108

465

Exclusions for E4_PCOS_CONSORTIUM

1042

4793

1.37

19.25

1.3

1.4

3.67

3.64

mmol/l

0.45

973

4500

Excessive, frequent and irregular menstruation

595

2180

1.53

19.24

1.3

1.2

3.60

mmol/l

0.02

564

2047

Benign neoplasm of other and unspecified endocrine glands

193

955

2.06

19.21

1.2

1.3

3.65

3.81

mmol/l

1.37

176

892

Superficial injury of lower leg

344

2040

1.71

19.11

1.2

1.4

3.79

3.69

mmol/l

0.92

316

1926

Volume depletion

125

519

2.46

19.08

1.3

1.5

4.02

3.77

mmol/l

1.36

109

487

Parkinson's disease

185

903

2.08

19.05

1.3

1.2

3.87

3.92

mmol/l

0.27

172

838

Mycoses

351

2097

1.69

18.97

1.4

1.3

3.85

3.76

mmol/l

0.56

324

1969

Other disorders of glucose regulation and pancreatic internal secretion

142

627

2.32

18.93

1.5

1.7

4.70

3.70

mmol/l

7.49

127

589

Other infectious diseases

126

528

2.44

18.92

1.3

3.89

3.80

mmol/l

0.30

117

491

Other and unspecified tonsillitis

509

2808

1.55

18.85

1.4

1.2

3.68

3.64

mmol/l

0.36

473

2657

Acute alcohol intoxication

341

2025

1.70

18.83

1.2

1.3

3.94

3.82

mmol/l

1.21

318

1904

Urticaria and erythema

517

3394

1.54

18.80

1.5

1.4

3.64

3.67

mmol/l

0.26

472

3193

Cytomegalovirus infection, IBD co-morbidity

136

4.11

18.79

1.6

1.2

3.84

3.76

mmol/l

0.15

127

Acetic acid derivatives and related substances

379

1166

1.71

18.77

1.2

1.3

3.77

3.87

mmol/l

0.79

354

1093

Fasciculation

5.48

18.73

1.3

1.2

3.66

3.69

mmol/l

0.05

Diseases of liver

432

2726

1.60

18.73

1.2

1.3

4.06

3.79

mmol/l

3.43

398

2574

Parkinson's disease, strict definition

170

810

2.13

18.68

1.3

1.2

3.87

3.93

mmol/l

0.28

158

748

Fracture of lumbar spine and pelvis

258

1417

1.84

18.63

1.2

1.3

3.83

3.84

mmol/l

0.06

231

1317

Emotional disorders starting during childhood or adolecense, excluding more controls

299

2.93

18.55

3.1

2.0

3.49

3.40

mmol/l

0.51

277

Disorders of conjunctiva

1132

7142

1.33

18.38

1.3

3.71

3.69

mmol/l

0.21

1071

6693

Undetermined asthma, excluding more controls

176

854

2.09

18.38

1.4

1.2

3.79

3.69

mmol/l

0.49

159

811

Other/unspecified cytomegaloviral diseases

121

4.30

18.34

1.6

1.2

3.84

3.78

mmol/l

0.12

113

Dislocation, sprain and strain of joints and ligaments at neck level

244

1332

1.86

18.16

1.2

1.3

3.58

3.66

mmol/l

0.99

229

1246

Other disorders of bladder

157

734

2.18

18.15

1.2

3.86

3.89

mmol/l

0.09

144

683

Covid-19 suspected case

318

1877

1.72

18.04

1.3

1.4

3.84

3.65

mmol/l

2.21

306

1753

Alcohol dependence

358

2179

1.66

18.02

1.2

3.99

3.84

mmol/l

1.66

333

2053

Other diseases of upper respiratory tract

1554

6329

1.29

17.89

1.3

3.70

3.75

mmol/l

0.97

1448

5950

Other disorders of bone

290

1674

1.76

17.84

1.3

3.68

3.72

mmol/l

0.29

274

1572

Undetermined asthma

176

864

2.07

17.83

1.4

1.2

3.79

3.70

mmol/l

0.42

159

819

Inflammatory disease of uterus

226

1212

1.90

17.80

1.1

1.2

3.64

3.61

mmol/l

0.27

208

1142

Vitamin deficiency, wide

331

2.81

17.77

1.2

1.5

3.83

3.76

mmol/l

0.25

310

Vitamin deficiency

331

2.81

17.77

1.2

1.5

3.83

3.76

mmol/l

0.25

310

Deforming dorsopathies

341

2057

1.67

17.75

1.3

3.67

3.73

mmol/l

0.49

315

1930

Soft tissue disorders related to use, overuse and pressure

326

1944

1.69

17.75

1.2

1.3

3.76

3.81

mmol/l

0.38

298

1832

Dystonia

383

2.66

17.69

1.2

1.3

3.77

mmol/l

0.00

362

Injuries to the knee and lower leg

1657

7498

1.27

17.61

1.3

3.79

3.72

mmol/l

1.88

1554

7043

Mixed and other personality disorders

142

647

2.25

17.60

1.2

1.3

3.97

3.66

mmol/l

2.18

132

604

Early lumbar disc prolapse, operated

151

704

2.18

17.59

1.1

1.2

3.59

3.67

mmol/l

0.56

145

668

Sequelae of injuries, of poisoning and of other consequences of external causes

329

1973

1.69

17.59

1.3

3.78

3.77

mmol/l

0.05

299

1849

Anterior Iridocyclitis

285

1646

1.76

17.51

1.3

3.78

3.77

mmol/l

0.09

267

1538

Other metabolic disorders

189

960

2.00

17.50

1.4

1.3

3.70

3.63

mmol/l

0.39

178

901

Chronic periapical parodontitis

280

1613

1.76

17.35

1.5

1.2

3.91

3.77

mmol/l

0.97

266

1520

Diseases of oral cavity, salivary glands and jaws

1279

5016

1.31

17.28

1.7

1.3

3.76

3.71

mmol/l

0.74

1197

4723

Alcohol abuse, main dg

234

1281

1.86

17.27

1.2

1.4

3.94

3.76

mmol/l

1.75

220

1201

Problems related to lifestyle

164

796

2.10

17.25

1.2

1.3

3.98

3.68

mmol/l

1.89

155

750

Erysipelas

631

3993

1.45

17.20

1.2

4.00

3.77

mmol/l

4.72

591

3768

Cytomegaloviral disease

145

3.84

17.19

1.6

1.2

3.84

3.68

mmol/l

0.35

135

Acute and subacute iridocyclitis

269

1537

1.77

17.18

1.3

3.80

3.75

mmol/l

0.30

252

1435

Voice disturbances

338

2055

1.66

17.14

1.2

1.3

3.66

3.74

mmol/l

1.02

313

1937

All influenza (not pneumonia)

221

1191

1.88

17.12

1.4

3.94

3.76

mmol/l

1.21

201

1121

Anti-inflammatory and antirheumatic products, non-steroids

415

1292

1.63

17.07

1.4

1.5

3.68

3.82

mmol/l

1.52

385

1215

Conjunctivitis

1030

6756

1.34

17.01

1.4

1.3

3.70

3.68

mmol/l

0.18

974

6335

Adrenocortical insufficiency

246

3.08

16.98

1.4

3.56

3.69

mmol/l

0.44

228

Other heart diseases, wide

1348

6487

1.30

16.96

1.3

3.85

3.70

mmol/l

4.56

1255

6104

Acute alcohol intoxication, ICD10

284

1655

1.74

16.93

1.2

1.3

3.94

3.77

mmol/l

1.71

264

1554

Other and unspecified iron deficiency

388

2447

1.60

16.88

1.3

1.4

3.92

3.74

mmol/l

2.24

364

2286

KRA_PSY_EATING, excluding more controls

125

547

2.32

16.86

1.1

1.4

3.61

3.49

mmol/l

0.66

116

517

Other disorders of skin and subcutaneous tissue

841

5639

1.37

16.82

1.4

1.3

3.92

3.75

mmol/l

3.07

779

5301

Disorders of synovium and tendon

672

4265

1.43

16.79

1.3

3.77

3.72

mmol/l

0.68

630

4012

Dental caries 1

1061

4060

1.34

16.62

1.5

1.3

3.75

3.72

mmol/l

0.39

985

3823

Dental caries, including avohilmo

1060

4057

1.34

16.60

1.5

1.3

3.75

3.72

mmol/l

0.38

984

3820

Disorders of skin appendages

646

4545

1.43

16.52

1.3

3.81

3.70

mmol/l

1.66

609

4281

Social phobias

134

617

2.21

16.18

1.5

1.3

3.57

3.61

mmol/l

0.23

127

581

Hypermobility syndrome

104

431

2.48

16.14

1.2

1.4

3.44

3.66

mmol/l

1.86

404

Bacterial pneumonia, not elsewhere classified

462

2702

1.53

16.06

1.5

1.3

3.83

3.77

mmol/l

0.60

424

2552

Diaphragmatic hernia

426

2781

1.55

15.98

1.2

1.3

3.71

3.83

mmol/l

1.62

388

2615

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

260

2.94

15.96

1.6

1.2

3.81

3.88

mmol/l

0.22

240

Internal derangement of knee

500

3367

1.49

15.95

1.2

1.3

3.75

3.77

mmol/l

0.12

469

3175

Bacterial pneumoniae

488

2892

1.51

15.95

1.4

1.3

3.82

3.76

mmol/l

0.53

447

2733

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

528

3599

1.48

15.95

1.2

1.3

3.76

3.65

mmol/l

1.53

498

3391

Disorders of choroid and retina

978

5354

1.34

15.90

1.3

4.29

3.74

mmol/l

23.34

916

5032

Polycystic ovarian syndrome, consortium definition

968

4367

1.35

15.84

1.3

1.2

3.67

3.61

mmol/l

1.15

908

4094

Alcohol withdrawal state with delirium

113

491

2.36

15.75

1.2

4.15

3.88

mmol/l

1.76

107

461

Urticaria

426

2792

1.54

15.75

1.5

1.4

3.60

3.64

mmol/l

0.41

388

2632

Disorders of mineral metabolism

119

529

2.30

15.69

1.3

1.4

3.86

3.72

mmol/l

0.54

109

497

Other and unspecified types of non-Hodgkin lymphoma, hilmo

263

2.91

15.64

1.6

1.2

3.81

3.85

mmol/l

0.12

247

Continuous positive airway pressure

234

1133

1.80

15.50

1.5

3.89

3.50

mmol/l

5.84

217

1090

Ovarian cyst

532

2082

1.49

15.40

1.2

3.60

3.61

mmol/l

0.15

501

1954

Obesity and other hyperalimentation

823

6041

1.36

15.35

1.2

1.3

4.04

3.67

mmol/l

14.06

767

5667

Diseases of pulp and periapical tissues, including avohilmo

1519

6271

1.26

15.26

1.3

3.79

3.70

mmol/l

2.57

1421

5901

Obesity

818

6010

1.36

15.24

1.2

1.3

4.05

3.67

mmol/l

14.45

762

5639

Insulin, intermediate and long-acting

672

4738

1.40

15.21

1.2

1.3

5.66

3.63

mmol/l

87.34

629

4468

Trochanteric bursitis

170

877

1.97

15.10

1.2

3.74

3.77

mmol/l

0.12

156

829

Dental pulpitis 1

1519

6280

1.26

15.10

1.3

3.78

3.70

mmol/l

2.42

1421

5910

Bacterial pneumonia (organism specified)

525

3287

1.46

15.10

1.4

1.3

3.81

3.78

mmol/l

0.24

483

3087

Dental pulpitis 4

1519

6279

1.26

15.09

1.3

3.78

3.70

mmol/l

2.42

1421

5909

Other symptoms and signs involving the urinary system

146

716

2.08

15.01

1.3

3.89

3.82

mmol/l

0.25

140

667

Superficial injury of abdomen, lower back and pelvis

215

1199

1.82

15.00

1.3

1.4

3.71

3.72

mmol/l

0.08

202

1122

Hyperosmolality and hypernatraemia

5.28

14.99

1.5

4.68

3.75

mmol/l

2.20

Disorders of lens

836

3895

1.36

14.98

1.3

4.14

3.79

mmol/l

9.86

785

3671

Iron deficiency anaemia

479

3217

1.49

14.96

1.3

3.94

3.73

mmol/l

1.69

449

3012

Use of pramipexole

261

1540

1.72

14.92

1.2

1.3

3.74

3.81

mmol/l

0.56

243

1443

Sequelae of injuries of head

380

2.52

14.91

1.5

1.3

3.83

3.72

mmol/l

0.42

355

Other diseases of hard tissues of teeth

866

4819

1.35

14.90

1.8

1.2

3.68

3.71

mmol/l

0.26

811

4544

Need for other prophylactic measures

418

2.44

14.80

2.7

1.5

3.84

3.71

mmol/l

0.53

393

Assault

206

1143

1.83

14.65

1.2

1.3

3.86

3.67

mmol/l

1.40

187

1080

Use of glatiramer acetate

119

3.90

14.58

1.1

1.4

3.67

3.61

mmol/l

0.15

111

Diseases of male genital organs

696

2517

1.41

14.58

1.2

1.5

3.90

3.86

mmol/l

0.28

649

2378

Hyperlipidaemia, other/unspecified

416

2606

1.52

14.55

1.2

1.3

4.14

3.78

mmol/l

6.16

386

2446

Persons with potential health hazards related to communicable diseases

551

3829

1.44

14.55

1.5

1.4

3.57

3.62

mmol/l

0.58

525

3596

Nutritional anaemias

557

3804

1.43

14.47

1.3

3.98

3.74

mmol/l

2.53

524

3554

Secondary and unspecified malignant neoplasm of lymph nodes

122

568

2.19

14.42

1.8

1.3

3.82

3.83

mmol/l

0.03

111

530

Non-allergic asthma (mode)

240

1387

1.73

14.27

1.2

1.3

3.79

3.68

mmol/l

0.94

217

1318

Unspecified/other endometriosis

152

771

2.01

14.26

1.2

3.46

3.55

mmol/l

0.81

142

723

Fall on and from stairs and steps

321

2021

1.61

14.23

1.2

1.4

3.83

3.75

mmol/l

0.64

292

1898

Conductive and sensorineural hearing loss

963

5083

1.32

14.18

1.3

3.78

3.79

mmol/l

0.05

897

4787

Other obstetric conditions, not elsewhere classified

481

2119

1.49

14.16

1.2

3.47

3.52

mmol/l

0.74

454

1970

Adverse effects, not elsewhere classified

282

1724

1.66

14.14

1.2

1.5

3.59

3.66

mmol/l

0.79

269

1609

Ptosis of eyelid

143

712

2.04

14.14

1.4

1.3

3.79

3.80

mmol/l

0.06

136

665

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

119

554

2.19

14.08

1.3

3.80

3.70

mmol/l

0.47

109

521

Dental pulpitis 2, only avohilmo

964

3736

1.33

14.08

1.5

1.3

3.77

3.72

mmol/l

0.62

891

3523

Hypothyroidism, strict autoimmune, 3 medication purchases required

1103

5846

1.29

14.02

1.2

1.3

3.78

3.70

mmol/l

1.60

1030

5485

Non-allergic asthma (mode), excluding more controls

240

1394

1.72

14.02

1.2

1.3

3.79

3.67

mmol/l

1.03

217

1324

Postprocedural endocrine and metabolic disorders, not elsewhere classified

168

888

1.92

13.95

1.4

1.2

3.68

3.65

mmol/l

0.15

157

833

177

3.23

13.91

1.1

1.2

3.80

3.73

mmol/l

0.16

167

Conjunctivitis (acute, non atopic)

381

2499

1.53

13.88

1.5

3.73

3.66

mmol/l

0.60

367

2353

Dental pulpitis 2

942

3650

1.33

13.84

1.5

1.3

3.78

3.72

mmol/l

0.98

867

3441

Immunodeficiencies

376

2.47

13.82

2.0

1.7

3.66

3.73

mmol/l

0.26

356

Leisure time condition

241

1425

1.71

13.74

1.4

3.78

3.73

mmol/l

0.25

223

1329

Noninfective enteritis and colitis

607

4365

1.40

13.74

1.3

1.4

3.78

3.72

mmol/l

0.63

568

4110

Fracture of skull and facial bones

279

1713

1.65

13.73

1.2

1.3

3.75

3.76

mmol/l

0.01

251

1614

Congenital malformations, deformations and chromosomal abnormalities

811

5848

1.34

13.70

1.3

3.71

3.68

mmol/l

0.34

767

5483

Other noninfective gastroenteritis and colitis

321

2038

1.59

13.70

1.3

1.5

3.76

3.70

mmol/l

0.36

299

1904

Vascular syndromes of brain in cerebrovascular disorders

215

2.96

13.69

1.3

4.16

3.91

mmol/l

0.72

199

Chronic diseases of tonsils and adenoids

1119

5524

1.29

13.69

1.2

1.4

3.69

3.73

mmol/l

0.45

1050

5202

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

470

2075

1.48

13.66

1.2

3.48

3.51

mmol/l

0.51

444

1930

Monoamine oxidase A inhibitors

148

755

1.99

13.63

1.1

1.2

3.80

3.79

mmol/l

0.06

141

709

Other symptoms and signs involving the circulatory and respiratory systems

433

2.33

13.62

1.2

1.4

4.00

3.69

mmol/l

1.59

401

Oxicams

294

1015

1.66

13.62

1.2

1.3

3.84

3.90

mmol/l

0.33

276

954

Disorders of muscles

133

654

2.07

13.60

1.1

1.3

3.90

3.78

mmol/l

0.55

125

619

Oter anti-inflammatory and antirheumatic agents, non-steroids

273

902

1.69

13.51

1.1

1.3

3.82

3.94

mmol/l

0.76

244

848

Persons encountering health services for specific procedures, not carried out

115

538

2.18

13.45

1.2

1.3

3.92

3.72

mmol/l

0.99

104

506

Acute renal failure

226

1322

1.73

13.38

1.3

4.14

3.85

mmol/l

2.08

197

1230

Explicit bacterial Sepsis

122

585

2.12

13.33

1.8

1.4

3.90

3.75

mmol/l

0.54

115

548

Appendectomy

873

6422

1.32

13.32

1.2

1.3

3.66

3.72

mmol/l

1.25

819

6029

Abnormal weight loss

124

600

2.11

13.30

1.2

1.5

3.70

3.78

mmol/l

0.30

115

561

Infections with a predominantly sexual mode of transmission

439

2999

1.48

13.30

1.3

1.2

3.70

3.62

mmol/l

0.87

410

2819

Obesity due to excess calories

603

4363

1.39

13.29

1.2

1.3

4.12

3.67

mmol/l

14.68

564

4111

Weight loss

135

674

2.04

13.29

1.6

1.5

3.68

3.76

mmol/l

0.35

125

632

Secondary uncertain malignant neoplasm

157

825

1.93

13.29

1.7

1.3

3.80

3.85

mmol/l

0.20

145

764

Thrombocytopenia, unspecified

105

477

2.25

13.24

2.8

1.3

3.83

3.82

mmol/l

0.03

445

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1282

6946

1.26

13.24

1.6

1.3

3.90

3.70

mmol/l

6.57

1208

6525

Metatarsalgia

129

634

2.07

13.24

1.1

1.4

3.79

3.78

mmol/l

0.04

121

601

Lesion of ulnar nerve

177

968

1.85

13.22

1.2

3.90

3.77

mmol/l

0.90

164

910

6-mercaptopurine

188

3.07

13.15

9.0

1.4

3.54

3.58

mmol/l

0.11

177

Spondyloarthritis

229

1354

1.71

13.04

1.2

3.77

3.78

mmol/l

0.02

210

1263

Other disorders of adrenal gland

332

2.51

12.98

1.4

1.5

3.52

3.70

mmol/l

0.73

312

Insulin, combination of fast acting with intermediate-acting or long-acting

745

5148

1.34

12.92

1.3

5.52

3.62

mmol/l

89.36

696

4847

Paralytic ileus and intestinal obstruction

289

1816

1.61

12.92

1.3

3.77

3.83

mmol/l

0.41

263

1707

Sensorineural hearing loss

885

4734

1.31

12.87

1.3

3.78

3.81

mmol/l

0.30

824

4457

Sequelae with surgical and medical care as external cause

241

1452

1.68

12.83

1.4

1.3

3.74

3.82

mmol/l

0.50

227

1358

Diabetic retinopathy, excluding more controls

298

1040

1.63

12.82

1.3

1.2

5.34

4.36

mmol/l

13.74

281

973

Mental and behavioural disorders due to opioids

281

2.64

12.78

1.3

1.4

3.93

3.63

mmol/l

1.14

264

Hernia of abdominal wall, postoperative

193

1094

1.78

12.78

1.2

1.1

3.90

3.84

mmol/l

0.28

173

1036

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1208

5664

1.27

12.77

2.0

1.2

3.67

3.77

mmol/l

2.96

1141

5315

Malignant neoplasm, wide definition for exclusion

1208

5665

1.27

12.75

2.0

1.2

3.67

3.77

mmol/l

2.96

1141

5316

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1207

5664

1.27

12.68

2.0

1.2

3.67

3.77

mmol/l

2.94

1140

5315

Insulin medication

744

4777

1.34

12.64

1.3

5.52

3.51

mmol/l

97.04

695

4499

Other enthesopathy of foot (+metatarsalgia)

134

681

2.00

12.54

1.1

1.4

3.78

3.76

mmol/l

0.08

126

644

Dental caries 3

1098

4396

1.28

12.54

1.4

3.74

3.71

mmol/l

0.43

1020

4142

Diseases of the digestive system

521

3707

1.41

12.51

1.4

3.84

3.77

mmol/l

0.81

480

3479

Acute appendicitis, no complications

753

5678

1.33

12.47

1.2

3.72

3.73

mmol/l

0.13

709

5341

Fenamates

199

760

1.78

12.34

1.3

3.65

3.80

mmol/l

1.22

188

714

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

104

485

2.18

12.30

1.4

1.2

3.82

3.96

mmol/l

0.47

448

Disturbance of activity and attention

166

900

1.85

12.29

1.2

1.8

3.63

3.51

mmol/l

0.99

158

844

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

362

2421

1.51

12.28

1.3

3.69

3.78

mmol/l

1.01

336

2286

Abnormal blood-pressure reading, without diagnosis

305

2.52

12.22

1.3

1.4

3.92

3.65

mmol/l

0.99

287

Dental caries 1, only avohilmo

1055

4221

1.28

12.18

1.3

1.4

3.75

3.73

mmol/l

0.20

981

3971

Other respiratory disorders and diseases

219

1307

1.69

12.09

1.5

1.4

4.01

3.83

mmol/l

1.40

200

1216

Other diseases of the respiratory system

219

1307

1.69

12.09

1.5

1.4

4.01

3.83

mmol/l

1.40

200

1216

Maternal care for other conditions predominantly related to pregnancy

298

1893

1.57

12.08

1.2

3.61

3.51

mmol/l

1.05

277

1758

Algoneurodystrophy

243

2.72

12.05

1.2

1.3

3.65

3.73

mmol/l

0.24

229

Menorrhagia

484

1867

1.44

12.02

1.2

3.63

3.64

mmol/l

0.10

448

1753

Tinnitus

288

1843

1.58

12.01

1.2

1.3

3.65

3.79

mmol/l

1.87

271

1743

Acute pharyngitis

213

1256

1.70

12.01

1.4

1.3

3.66

3.63

mmol/l

0.17

202

1187

Unspecified acute lower respiratory infection

197

1146

1.74

11.99

1.3

1.4

4.09

3.75

mmol/l

2.43

187

1077

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

109

524

2.12

11.96

1.2

1.4

3.88

3.67

mmol/l

1.11

100

494

Mental and behavioural disorders due to sedatives or hypnotics

112

545

2.10

11.91

1.1

1.3

3.77

3.76

mmol/l

0.04

102

513

Impingement syndrome of shoulder

290

1862

1.57

11.90

1.3

1.2

3.87

3.81

mmol/l

0.39

270

1768

Enterocolitis due to Clostridium difficile

131

674

1.97

11.86

1.7

1.3

3.92

3.81

mmol/l

0.52

125

627

Gingivitis and periodontal diseases

1206

4968

1.26

11.86

1.3

1.2

3.82

3.72

mmol/l

2.25

1125

4678

Dental operations

850

3333

1.31

11.77

1.4

1.3

3.77

3.74

mmol/l

0.25

792

3113

Excessive vomiting in pregnancy

131

678

1.97

11.71

1.2

3.64

3.57

mmol/l

0.36

121

632

Cellulitis

273

1737

1.59

11.69

1.7

1.3

4.07

3.75

mmol/l

3.04

264

1627

Cutaneous abscess, furuncle and carbuncle

327

2166

1.52

11.67

1.3

3.97

3.72

mmol/l

2.71

308

2027

Other gastritis (incl. Duodenitis)

259

1628

1.61

11.66

1.3

4.05

3.84

mmol/l

0.86

241

1540

Coagulation defects, purpura and other haemorrhagic conditions

242

1499

1.63

11.61

2.0

1.4

3.79

3.73

mmol/l

0.33

222

1400

Hypermetropia

115

572

2.05

11.53

1.6

1.9

3.50

3.65

mmol/l

1.47

107

540

Candidiasis

179

1026

1.77

11.52

1.4

1.3

3.90

3.70

mmol/l

1.18

162

957

Other disorders of eyelid

470

3228

1.42

11.50

1.3

3.74

3.80

mmol/l

0.68

440

3035

Fall on same level involving ice and snow

697

5280

1.33

11.45

1.3

3.75

3.74

mmol/l

0.09

641

4968

Haemorrhage from respiratory passages

379

2405

1.47

11.39

1.4

1.3

4.03

3.79

mmol/l

1.58

351

2267

TMD related pain

268

2.58

11.38

1.1

1.3

3.60

3.70

mmol/l

0.34

250

Special screening examination for other diseases and disorders

455

2.16

11.28

1.3

1.2

4.25

3.68

mmol/l

2.96

431

Dental pulpitis 4, only avohilmo

1505

6460

1.22

11.26

1.2

1.3

3.77

3.71

mmol/l

1.56

1406

6082

Mental disorders, not otherwise specified

134

709

1.92

11.24

1.1

1.3

3.77

3.65

mmol/l

0.58

128

665

Other diseases of jaws

102

492

2.11

11.11

1.3

3.62

3.76

mmol/l

0.81

464

Diverticular disease of intestine

814

4169

1.30

11.08

1.2

1.3

3.81

3.82

mmol/l

0.06

760

3932

Dental pulpitis 1, only avohilmo

1507

6482

1.22

11.07

1.2

1.3

3.77

3.71

mmol/l

1.55

1409

6101

Assault by bodily force

122

630

1.97

11.01

1.2

1.4

3.80

3.67

mmol/l

0.71

112

590

Intestinal stricture

331

2226

1.50

10.98

1.4

1.3

3.73

3.83

mmol/l

0.92

303

2085

Convergent concomitant strabismus

100

482

2.12

10.95

1.1

1.8

3.67

3.62

mmol/l

0.17

452

Autonomic disorders

118

3.42

10.94

1.3

1.1

3.74

mmol/l

0.01

108

Lateral epicondylitis

165

939

1.78

10.89

1.2

1.3

3.72

3.76

mmol/l

0.20

158

885

Arthrosis

917

3941

1.28

10.87

1.2

3.79

3.78

mmol/l

0.04

858

3701

Diabetic neuropathy

127

664

1.93

10.83

1.3

5.78

4.67

mmol/l

6.92

115

625

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

229

1426

1.62

10.80

1.2

1.3

3.58

3.60

mmol/l

0.13

212

1346

Pulmonary heart disease

308

2048

1.52

10.79

1.4

1.3

3.80

3.83

mmol/l

0.13

282

1916

Pulmonary embolism

308

2048

1.52

10.79

1.4

1.2

3.80

3.83

mmol/l

0.13

282

1916

Other female pelvic inflammatory diseases

214

1312

1.65

10.75

1.2

3.59

3.66

mmol/l

0.75

200

1240

Misadventures to patients during surgical and medical care

174

1010

1.74

10.74

1.4

1.3

3.75

3.79

mmol/l

0.19

168

946

Unspecified haematuria

446

2719

1.41

10.72

1.4

1.3

3.95

3.85

mmol/l

0.80

412

2558

Venous thromboembolism

591

4283

1.35

10.72

1.3

1.2

3.81

3.80

mmol/l

0.05

548

4016

Abnormal findings on diagnostic imaging of other body structures

158

894

1.79

10.67

1.3

3.87

3.81

mmol/l

0.19

147

838

Any event in cancer register

1241

5984

1.23

10.64

1.8

1.2

3.64

3.76

mmol/l

3.92

1170

5621

Secondary hypertension

470

2.10

10.53

1.2

1.4

4.19

3.56

mmol/l

4.14

441

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

128

683

1.90

10.49

1.6

1.3

3.95

3.79

mmol/l

0.69

120

637

Chronic rhinitis, nasopharyngitis and pharyngitis

399

2808

1.43

10.47

1.3

1.4

3.65

3.73

mmol/l

0.99

362

2648

Other retinal disorders

689

4225

1.32

10.45

1.4

1.3

4.52

3.74

mmol/l

27.56

643

3966

Dental caries 1 and operation codes

1130

4663

1.25

10.41

1.5

1.3

3.75

3.72

mmol/l

0.42

1059

4376

Asthma/COPD (KELA code 203)

1271

7339

1.23

10.40

1.2

1.3

3.74

3.71

mmol/l

0.30

1181

6904

Keratitis

424

3025

1.41

10.31

1.2

1.3

3.88

3.74

mmol/l

1.60

398

2847

Streptococcal septicaemia

103

513

2.04

10.30

1.9

1.4

4.00

3.76

mmol/l

0.87

482

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS